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ABSTRACT 
 
Augmentation of Extracellular Glutamate in the Ventromedial Prefrontal Cortex and its Role 
During the Incubation of Cocaine Craving in Rat 
 
by 
 
Christina Borom Shin 
 
Incubation of craving is the phenomenon in which craving intensifies over the course of 
abstinence. Although understanding craving may be key in understanding why relapse 
occurs, not much is known about craving, especially the underlying mechanisms that occur 
in the brain. Clinical and preclinical models have recently implicated the ventromedial 
prefrontal cortex as one of the key regions in this phenomenon. In order to further 
characterize this region’s role in incubation, a variety of behavioral, pharmacological, and 
molecular techniques are used to examine how withdrawal from long access cocaine self-
administration directly affects the glutamatergic system. The series of experiments detailed 
in this dissertation aim to: (1) characterize extracellular glutamate fluctuations in the vmPFC 
during the incubation of cocaine-seeking, (2) characterize metabotropic glutamate receptor 
(mGlu) 2/3 changes during both short term and long term withdrawal, and (3) to determine 
the functional relevance of endogenous glutamate in the two subregions of the vmPFC. 
Taken together, these experiments suggest that although there seem to be no changes in 
mGlu2/3 at either point of withdrawal, glutamate in the prelimbic cortex of the vmPFC is 
functionally relevant in the incubation of cocaine seeking. Together, these results suggest 
  vii 
pharmacotherapeutic strategies geared toward damping excitatory glutamate drive within 
corticofugal projections from the prelimbic cortex may be effective to prevent incubated 
cue-induced craving during protracted abstinence.  
  viii 
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Chapter 1: 
General Introduction 
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1.1 Cocaine Addiction: A Public Health Concern 
1.1.1 Prevalence of Cocaine Addiction 
Cocaine addiction is a chronic brain disease characterized by compulsive drug use and 
drug-seeking, despite negative consequences. It involves a cycle of intoxication, bingeing, 
withdrawal, and craving (Goldstein & Volkow, 2011). In 2011, about 2.5 million emergency 
department visits involved drug misuse or abuse, a 52% increase since 2004 (Substance 
Abuse and Mental Health Services Administration, 2013a). Of the 2.5 million visits, over 
40% were cocaine-related, the highest in the illicit drug category (Substance Abuse and 
Mental Health Services Administration, 2013a). In 2012, 8.0 million persons aged 12 or 
older needed treatment for an illicit drug use problem (Substance Abuse and Mental Health 
Services Administration, 2013a). Of these people, only 1.5% received the treatment they 
needed, leaving 6.5 million people (2.5% of the total population) untreated.  
The latest results of the Substance Abuse and Mental Health Services Administration 
survey indicate that of the 21.7 million persons aged 12 or older with general substance 
abuse problems in 2015, just under 1 million people aged 12 or older were diagnosed with a 
cocaine use disorder, with about 0.1% of all adolescents aged 12 to 17 having a cocaine use 
disorder in the past year (Center for Behavioral Health Statistics and Quality, 2016). Of the 
21.7 million persons with substance abuse issues, only 10.8% received the treatment they 
needed (Center for Behavioral Health Statistics and Quality, 2016). This is problematic as 
addicts relapse at least once on their road to recovery, with the probability of relapse 
remaining high even after months of abstinence. With this lack of treatment for addiction, 
especially any effective treatment for cocaine in particular, addicts have a difficulty journey 
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to full recovery. Cocaine addiction is a particularly interesting case as we know cocaine’s 
mechanisms of action on the brain, yet we still do not have any effective treatments for 
Cocaine Use Disorder. 
1.1.2 Cocaine Craving, Relapse, and its Triggers  
One of the hallmark features of addiction is relapse - the resumption of drug-taking 
following a period of abstinence. In humans, cocaine relapse can be instigated by a number 
of stimuli, some of which include re-introduction to the drug itself (Jaffe et al., 1989), 
stressors (Sinha et al., 1999), cocaine-associated contexts, and cocaine-associated cues 
(Childress et al., 1993a; Childress et al., 1993b). Cocaine-associated cues and contexts are 
able to induce relapse as they elicit cocaine craving, or a powerful yearning for cocaine. One 
of the ways this intense craving manifests is an emotional state that is engulfed by a 
perseveration of the cocaine high. This fervent state of craving is also coupled with a loss of 
encumberment from the negative consequences of the drug (Childress et al., 1999). The two 
culminate to a point where the addict can no longer tolerate sobriety and eventually relapses. 
As cocaine craving brought on by cocaine-associated cues has the susceptibility of extending 
into prolonged abstinence (Childress et al., 1993; Grimm et al., 2001; Goldstein & Volkow, 
2011), this dissertation will focus on this form of induced relapse.  
1.1.3 Cocaine Use is Associated with Prefrontal Cortex Deficits in Humans  
The prefrontal cortex (PFC) is responsible for a myriad of important behaviors, including 
(but not limited to): inhibition control, attention, working memory, emotion, and motivation. 
These important faculties, and the regions responsible for these faculties, are known to be 
disrupted in individuals addicted to cocaine and other drugs of abuse (e.g., Goldstein & 
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Volkow, 2011; Koob & Volkow, 2016), and this disruption may account for the compulsive, 
relapsing nature of addiction.  
Cocaine addicts exhibit gross anatomical changes in their PFC. As measured by 
magnetic resonance imagining (MRI) scans, cocaine addicts have lower gray matter volumes 
in the orbital frontal cortex (OFC), as well as lower white matter volumes in the right 
anterior cingulate cortex and left inferior and medial frontal gyrus compared to healthy 
controls (Moreno-López et al., 2012). A positive correlation between impulsivity and gray 
matter volume in specifically the left inferior and middle frontal gyrus is observed in cocaine 
addicts but not in healthy controls (Moreno-López et al., 2012). Another study using MRI 
scans in healthy controls versus long-term cocaine users reported similar findings: cocaine 
use reduces gray matter volume in OFC and dorsolateral PFC (dlPFC) (Alia-Klein et al., 
2011).   
Those with cocaine use disorder also manifest different molecular changes in their PFC. 
For example, cocaine abusers are reported to have higher glucose and total creatine ratios in 
the pregenual anterior cingulate cortex (ACC) and the right dlPFC (Hulka et al., 2016). As 
higher cocaine hair concentrations were associated with lower glutamine/creatine ratios in 
the pregenual ACC, this suggested that cortical glutamate cycling is altered by cocaine use 
within the past 6 months (Hulka et al., 2016). A study using cDNA microarrays examined 
gene expression in the dlPFC from post-mortem male cocaine users and reported alterations 
in transcripts indicative of changes in mitochondria function, energy metabolism, and 
neuronal plasticity, among others, compared to healthy controls (Lehrmann et al., 2003). 
Chronic cocaine use was also associated with decreased expression of brain derived 
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neurotrophic factor (BDNF) 1 and 4 in the frontal cortex, as measured by BDNF mRNA 
levels through real time polymerase chain reaction (PCR) (Jiang et al., 2009).  
Along with the observed PFC deficits, cocaine addicts experience increased impulsivity 
due, in part, to frontostriatal dysfunction (e.g., Jentsch & Taylor, 1999). Indeed, cocaine 
users have altered cerebral blood flow in the OFC as measured by positron emission 
tomography (PET) imaging during a decision-making task that measures the ability to weigh 
short-term rewards against long-term losses (Bolla et al., 2003). More specifically, cocaine 
users experience increased activation in the OFC and less activation in the right dlPFC and 
left medial PFC compared to healthy controls (Bolla et al., 2003). As these changes were 
recorded in addicts abstinent for 25 days, these alterations of the PFC seem to be enduring. 
Chronic cocaine abusers also have impaired performance on reward/punishment 
contingencies during a gambling task, yet these impairments seem specific to long-term 
versus short-term rewards as users do not suffer generalized deficits in regards to choice and 
planning as measured by a normal card sorting task (Grant et al., 2000). In the delay-
discounting model of impulsivity, cocaine addicts have higher discount rates, or the 
reduction of the present value of a future reward, for real monetary rewards than do healthy 
controls, in conjunction with having higher discount rates for future rewards in general 
(Kirby et al., 2004). In addition, Bechara and colleagues report cocaine addicts closely 
resemble patients with bilateral lesions of the ventromedial PFC (vmPFC) on their ability to 
perform decision-making on electronic card gambling tasks (Bechara et al., 2001).  
Cocaine use is linked to basal hypofunction of the PFC in addicts (e.g., Volkow et al., 
2003), yet chronic cocaine users exhibit higher than usual PFC activation in response to 
cocaine-associated cues (e.g., Goldstein & Volkow, 2011). As regions of the PFC are known 
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to be involved in processing reward-associated cues (Kringelbach, 2005), higher activation 
of the PFC is thought to be associated with cocaine craving following cue exposure. Indeed, 
PFC activity has been positively correlated with self-reported craving (Wang et al., 1999; 
Garavan et al., 2000; Goldstein et al., 2007). A study using PET imaging reported PFC 
activation, along with increased heart rate and blood pressure, in 7-day abstinent cocaine 
addicts when discussing how they prepare their cocaine, versus a neutral theme interview 
(Wang et al., 1999). Another study using functional magnetic resonance imaging (fMRI) 
reported increased PFC activation when cocaine users watched a video of individuals 
smoking crack cocaine, compared to a sexually explicit film (Garavan et al., 2000). Using 
many different imaging techniques, numerous studies have since replicated the findings that 
the PFC exhibits increased activation in response to cocaine cues in addicts, relative to 
healthy controls (PET: Grant et al., 1996; Bonson et al., 2002; fMRI: Maas et al., 1998; 
functional connectivity MRI; Wilcox et al., 2011). In addition, transcranial magnetic 
stimulation (TMS) studies also indicate the PFC is a key region involved in craving, as 
repetitive TMS of the dlPFC significantly lowered instances of cocaine craving (Camprodon 
et al., 2007; Politi et al., 2008; Terraneo et al., 2016; Rapinesi et al., 2016), reduced overall 
cocaine intake 3-6 months after treatment (Bolloni et al., 2016), as well as decreased cocaine 
use up to 29 days compared to disulfiram-treated users (Terraneo et al., 2016).  
Additionally, increased connectivity between regions responsible for processing reward 
and reward cues (i.e., ventral striatum and orbital frontal cortex) seen in the brains of cocaine 
addicts may explain why addicts place high salience on cocaine-associated cues (Wilcox et 
al., 2011). Together, the evidence points to neurological alterations occurring in the PFC of 
  7 
cocaine addicts that may cause them to perseverate on drug cues over natural reward cues, 
which may ultimately lead to higher instances of relapse. 
1.1.4 Incubation of Craving in a Clinical Setting  
Although baseline craving dissipates in a time-dependent manner following cessation of 
drug-taking, drug-associated cues can elicit craving that intensifies during abstinence, a 
phenomenon dubbed “incubation of craving” (Gawin & Kleber, 1989; Tran-Nguyen et al., 
1998; Grimm et al., 2001; Lu et al., 2004; Pickens et al., 2011). Gawin and Kleber first 
reported this phenomenon in 1986 in their monumental study delineating enduring 
psychiatric disorder symptoms (such as major depressive disorder and attention deficit 
hyperactivy disorder) from symptoms brought on by cocaine-use binges (Gawin & Kleber, 
1986). This study described a three-phase sequence of post-cocaine abuse: 1) crash, 
immediate withdrawal symptoms such as dysphoria and anhedonia brought on by the end of 
a cocaine binge, 2) withdrawal, a short period of baseline functioning followed by a mild 
version of phase one in addition to perseveration on past cocaine binges and craving, and 3) 
extinction, a phase described by a baseline affective state before cocaine use dispersed with 
very few bouts of cocaine craving (Gawin & Kleber, 1986). After abstinence of drug-use and 
also the absence of craving for approximately 28 weeks, half the subjects reported feeling a 
fervent feeling of craving after exposure to cocaine-associated friends or environments 
(Gawin & Kleber, 1986). Since then, incubation of craving has been more comprehensively 
studied and it has been reported that in human cocaine addicts, craving in response to 
cocaine cues presents itself in an inverse U shape over the course of a year: peaking at 1 to 6 
months before declining after one year of abstinence (Parvaz et al., 2016).  
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Along with cocaine, incubation of craving has been characterized in humans addicted to 
a variety of drugs. For example, along with eliciting craving, heroin-associated cues were 
also able to increase cardiovascular measures (e.g., heart rate, systolic pressure) and 
negatively impact decision-making by increasing impulsivity in a gambling task in former 
heroin addicts who were abstinent for 1-24 months (Wang, G.B. et al., 2011). 
Methamphetamine abusers also report decreased craving during abstinence, with cue-
reinforced craving increasing until 3 months of abstinence and eventually decreasing and 
tapering off at 6 months of abstinence (Wang et al., 2013). Similar patterns have also been 
reported for nicotine (Bedi et al., 2011) and alcohol (Li et al., 2014).  
Unfortunately, not much research has been done on specific brain regions involved in 
incubated drug craving. What we do know is that PFC activity in response to drug-associated 
cues is known to be enduring. During short-term abstinence in heroin users, fMRI scans 
show that the PFC was activated when users were presented heroin-associated cues (Li et al., 
2012). These changes are also known to extend into long-term abstinence. Using fMRI 
imaging scans, Janes and colleagues (2009) reported the PFC is activated when smokers in 
extended abstinence are presented with cigarette-associated cues, but current smokers had 
little to no activation in these areas in response to smoking related cues (Janes et al., 2009). 
Another study focused on former heroin users on stable methadone treatment who were 5-24 
months abstinent, a subject profile typically associated with low heroin craving. These 
subjects exhibited increased PFC activation in response to heroin-associated cues but not to 
neutral cues, indicating heroin-associated cues are able to elicit strong PFC activation 
despite no experience of craving (Wang, W. et al., 2011). Together, these data indicate that 
in drug abusers, neural adaptations are occurring in the PFC during extended abstinence that 
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may render addicts more sensitive to drug-associated cues. As drug-associated cues are 
known to be a powerful trigger of relapse, the above mentioned changes may indicate why 
addicts are so prone to relapse during protracted abstinence.  
1.1.5 Drug Craving in Humans Versus Drug-Seeking in Rodents 
Addiction studies using human subjects are not ideal due to a variety of reasons, some of 
which include complex ethical issues (e.g., Scott & White, 2005) to the massive number of 
confounding variables that are impossible to control (e.g., environmental differences, 
genetics, health/disease comorbidity etc.). Due to these reasons, results of human addiction 
studies can only be correlative and never causal. Thus, many addiction researchers turn to 
animal models, especially rodent models, in order to infer causation. However, craving is an 
internal state that cannot be examined directly in animals. Thus, craving or the wanting of 
drug must be inferred from the animal’s behavior and the term “drug-seeking” is typically 
applied.   
For the purposes of this dissertation, drug-seeking is operationally defined as emitting an 
operant response (lever pressing) for delivery of drug-associated stimuli (20 second light and 
tone), in the absence of any drug delivery (i.e., under extinction conditions; see section 1.3.1. 
for a more detailed description of the paradigm). Presumably, the number of times the 
animal presses the lever in the absence of cocaine is thought to represent the motivation of 
the animal to obtain cocaine or how much the animal is seeking the drug. Thus drug-seeking 
is used as a proxy to drug craving.  
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1.2 Ventromedial Prefrontal Cortex  
1.2.1 PFC Homology: from Humans to Rodents 
Humans and primates differ from all other mammals due to our evolution of the PFC, 
making the study of this region in non-human animal models arguably problematic. While 
homologous regions have been postulated in many species, the PFC still remains enigmatic. 
The little we know is due to our research on other species, the conclusions from which we 
carry over to infer into our own behavior. Conclusions drawn from other species are done 
with caution, as homology of the brain is not consistent across species. If homology is not 
taken into account, misconceptions may arise in regards to brain function between species.  
One of the ways the PFC of primates has been defined over the years is by the presence 
of a granular layer (layer 4) in the cortex. Yet, this becomes problematic as the rodent brain 
completely lacks granular cortex and is only comprised of allocortex and agranular cortex 
(Wise, 2008). Clearly, no homolog exists between granular regions of primate PFC and 
rodent PFC, but homology between the species exists in the agranular regions of their PFCs. 
This has been argued for by cytoarchitectonics, topology, and corticostriatal organization 
between primate and rat PFCs (Wise, 2008). Thus, conclusions drawn from rat PFC studies, 
specifically regarding the delineation of the infralimbic, prelimbic, agranular insula, 
agranular orbital, and anterior cingulate cortices (ACC), can be cautiously generalized to 
humans, as they have presumed homologous areas within the primate PFC. For the purposes 
of this dissertation, this will suffice, as I will only be focusing on the ventromedial PFC (for 
reasoning see section 1.4.5).  
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This being said, in rodents, the PFC is located at the anterior tip of the frontal cortex and 
is comprised of the anterior cingulate, medial PFC, and orbital frontal cortex (OFC). Based 
on their thalamic inputs, the rodent prelimbic cortex (PL) is considered to be equivalent to 
Brodmann area (BA) 32, or the pregenual anterior cortex in humans, while the infralimbic 
cortex (IL) is equivalent to BA 25, or the subgenual anterior cortex in humans (Wise, 2008; 
Goldstein & Volkow, 2011; Gass & Chandler, 2013). The ACC corresponds to BA 32 and 
24, while the medial OFC to BA 11, 13, and 14 (Wise, 2008). 
1.2.2 Ventromedial Prefrontal Cortex Circuitry in the Rat 
From dorsal to ventral, the medial PFC (mPFC) is subdivided into the ACC, the PL, and 
the IL. Unfortunately, as these regions do not have well demarcated boundaries, many 
researchers simply divide the PFC in half into the dorsomedial PFC (dmPFC; ACC plus the 
dorsal portion of the PL) and ventromedial PFC (vmPFC; ventral portion of the PL plus the 
IL), although ample research has shown that the ACC, PL and IL differ vastly in their 
function. For example, general anatomical studies report that the ACC is involved in eye 
movement control, the PL in cognitive processes, and the IL in visceromotor processes, to 
name a few (Vertes, 2004). Along with these properties, the PL and IL have been 
anatomically and functionally linked with the limbic system (Vertes, 2004), thus making 
these subregions prime candidates involved in the addiction process. For the purposes of this 
dissertation, the vmPFC will be divided into the PL and IL regions of the mPFC.  
The PL and IL of the vmPFC are defined by their reciprocal connections with the 
mediodorsal nucleus of the thalamus (MDT): the central MDT projects to the PL while the 
ventromedial MDT projects to the IL (Vertes, 2004; Hoover & Vertes, 2007). Studies 
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injecting the retrograde tracer fluorogold (Hoover & Vertes, 2007), and the anterograde 
tracer phaseolus vulgaris-leucoagglutinin (Sesack et al., 1989; Vertes, 2004) have elucidated 
the intricate afferent and efferent connections of the PL and IL. As these two regions are 
interconnected to the whole brain, for simplicity’s sake, I will only focus on their 
connections with brain regions implicated in addiction. With this said, these anatomical 
studies report cortico-cortical projections from the PL to the insular, OFC, cingulate, IL, and 
to itself, with the PL being reciprocally connected to all these regions but itself. The IL also 
sends efferent projections to the same regions, but only receives afferent cortical projections 
from the cingulate cortex and itself. Both PL and IL are reciprocally connected to basolateral 
amgydala (BLA), a region known to be involved in reinforcer valuation, and also the ventral 
tegmental area (VTA), a region that is involved in generation of motivation and goal directed 
behavior. The PL and IL also send efferent projections to the shell and core of the nucleus 
accumbens, and to the central nucleus of the amygdala (CEA) - two regions also heavily 
implicated in addiction - although these regions do not send reciprocal connections back to 
the vmPFC (see Figures 1 and 2 for more detailed overview). It must be said that although 
these areas have similar connections to regions within the brain, they differ in the strength 
and density of their projections to each region (Sesack et al., 1989; Vertes, 2004; Hoover & 
Vertes, 2007). 
While extremely similar in their projections, there are distinct differences between these 
two regions. This becomes apparent in their projections to the amygdala, as the IL sends 
efferent projections to all the different nuclei of the amygdala, while the PL does not send 
efferents to specifically the anterior area, cortical, medial, and posterior amygdala Vertes, 
2004). Interestingly, the IL receives reciprocal connections from all regions of the amygdala 
  13 
excluding the CEA. Though the PL and IL both send projections to the two regions of the 
nucleus accumbens (NAC), they differ in their projection density. For example, the rostral-
caudal and dorsal portions of the PL send a majority of their efferents to the NAC core, 
while the ventral PL and IL send their efferents to the NAC shell (Vertes, 2004). Thus, 
though there is light overlap, the PL seems to preferentially project to the NAC core while 
the IL to the NAC shell (Ma et al., 2014). In addition, the IL sends efferent projections to the 
bed nucleus of the stria terminalis (BNST) and ventral pallidum, while the PL does not. Due 
to its prime connections with the reward centers of the brain, along with clinical evidence of 
dysfunction within the PFC following chronic cocaine use, and recent findings tying the 
vmPFC to cocaine craving (see Section 1.4), the vmPFC of the rodent will be the target 
region of study for this dissertation. 
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Figure 1. Afferent projections of the prelimbic and infralimbic cortex to different brain regions known to 
be involved in addiction. Adapted from results of Sesack et al., 1989 and Vertes, 2004. N: nucleus. 
 
 
 
 
 
 
 
  15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Efferent projections of the prelimbic and infralimbic cortex to different brain regions known to 
be involved in addiction. Adapted from results of Hoover & Vertes, 2007. N: nucleus. 
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1.3 Animal Models Implicating Glutamate in the Prefrontal Cortex in 
Addiction 
As many barriers exist in studying addiction in the human brain, the bulk of addiction 
research is traditionally done in animal models, in particular to investigate the cellular and 
molecular mechanisms of cocaine addiction in the brain. These models are reliable and have 
become well established, with different paradigms existing to measure the many facets of 
drug addiction. Of the different models, intravenous self-administration has high predictive 
as well as high construct validity, and is a reliable predictor of abuse liability in humans 
(Horton, 2013). It also most closely resembles the human condition of drug-taking compared 
to other preclinical models, as it allows the animal to control their own drug intake. Thus, 
the main behavioral paradigm used in this dissertation will be the self-administration model, 
in conjunction with other procedures.  
1.3.1 The Self-Administration Paradigm 
In the rodent model of self-administration, an indwelling catheter is inserted into the 
jugular vein, which allows direct intravenous delivery of drug. The rat is subsequently 
introduced to an operant chamber where they are conditioned to perform a response (such as 
pressing a lever) that results in the delivery of drug. This model is particularly unique as it 
gives the researcher control over many different aspects of drug taking, such as different 
schedules of reinforcement, speed of drug delivery, and pairing of different discrete cues to 
drug delivery. This model is also multifaceted as it allows for different training schedules 
(e.g., progressive ratio, extinction, reinstatement, etc.). It is thus considered the “gold 
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standard” procedure for measuring reinforcing effects of a drug, as well as drug 
consumption. 
Over the past few decades, the drug self-administration field has focused intense efforts 
on developing animal models of drug self-administration that better fit the clinical criterion 
for a diagnosis of substance use disorder/addiction. Such models should exhibit high levels 
of drug intake, an escalation of drug intake with subsequent drug experience, and continued 
drug intake in the face of negative consequences (e.g., punishment), as experienced by 
human addicts. One simple procedural modification that can accomplish these goals simply 
involves allowing animals longer access to the drug than has been historically employed in 
the literature (i.e., >2 hour/day). Indeed, ample evidence indicates that the pattern of drug 
intake observed under “long-access” (LgA; typically 4+ hours/day) paradigms is distinct 
from that observed under the more traditional “short-access” (ShA; ≤ 3 hours/day) paradigm. 
For instance, the ShA paradigm produces a stable, moderate intake of drug that is thought by 
some researchers in the field to best model recreational drug use, while the LgA paradigm 
more closely models addiction as rats exposed to this condition will show an escalated 
“binge-like” intake of drug, which is thought to model the more impulsive aspects of drug-
use that is key to addiction (Ahmed & Koob, 1998). For these reasons, LgA self-
administration (SA) will be utilized for the studies within this dissertation. 
With the SA paradigm, one can model the different cycles of addiction, recovery, and 
relapse naturally seen in humans. One procedure that is used to model relapse in rodents is 
the extinction-reinstatement paradigm. In this paradigm, animals are trained to self-
administer drug, quite often in the presence of drug-associated external neutral stimuli (e.g., 
tones and lights) that come to serve as conditioned reinforcers of the operant behavior.  Then 
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the drug primary reinforcer (and sometimes the conditioned reinforcer) is removed and the 
operant response undergoes extinction. Extinction is a process of new inhibitory learning 
during which the animal learns that the operant response no longer results in the presentation 
of the primary and/or conditioned reinforcer. As such, the animal learns to inhibit its operant 
response and behavioral output processing decreases across trials. Once the operant response 
has been extinguished to come pre-determined criterion/criteria, the operant response is 
“reinstated” or re-instigated, typically by presenting animals with one of the major triggers of 
relapse in humans: including re-exposure to the operant context, the drug-associated cues, 
the drug itself, or by exposure to a pharmacological or physical stressor. This extinction-
reinstatement paradigm has been the primary procedure for modeling drug relapse in animal 
models over the last two decades, and the good majority of our understanding of the 
psychobiological underpinnings of the chronic, relapsing nature of addiction, including 
deficits in PFC function, have been derived from studies using this particular animal model.  
(c.f., Bossert et al., 2013).  
1.3.2 The Role for Glutamate in Craving  
In animal models of addiction, drug context (e.g., Brown et al., 1992), drug cues (e.g. 
McFarland & Ettenberg, 1997), and re-exposure to cocaine (e.g., de Wit & Stewart, 1981) 
have all been reported to cause reinstatement of drug-seeking. Stressors, specifically the 
alpha 2 adrenoceptor antagonist, yohimbine (Shepard et al., 2004), or foot shock (Ahmed & 
Koob, 1997; Shaham et al., 2000), are also enough to induce reinstatement. As with humans, 
drug-associated cues are able to elicit intense drug-craving in rodent models of addiction, 
with the susceptibility to cue-elicited craving extending into prolonged abstinence (Childress 
et al., 1993; Grimm et al., 2001; Goldstein & Volkow, 2011). 
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Historically, the neurotransmitter dopamine has been the focus of the majority of 
addiction research as drugs of abuse increase its levels in the “reward centers” of the brain, 
such as the NAC, and thus is believed to underlie their rewarding effects (Kuhar, Ritz, & 
Boja, 1991; Di Chiara et al., 1993). Although dopamine may be critical in the addiction 
cycle, especially as it mediates incentive salience attribution to primary and conditioned 
reinforcers (Robinson & Berridge, 1993; Everitt & Robbins, 2006), dopamine appears to 
play a larger role in the early phases of the addiction process (Shultz, 1998; Jay, 2003; 
Kalivas & Volkow, 2005). The later stages of addiction are instead thought to be due to 
dysfunction of glutamate, as it is involved in long-term plasticity underpinning changes in 
cognitive dysfunction (e.g., inhibitory control deficits/impulsivity) that are known to occur 
during these stages (Kalivas & Volkow, 2005; Kalivas & O’Brien, 2008; Dalley, Everitt, & 
Robbins, 2011; Volkow et al., 2011). It is becoming increasingly clear that the processes 
underlying addiction is a combination of these two neurotransmitter systems. Indeed, the 
dopaminergic and glutamatergic systems are intimately interconnected as glutamate can 
modify the activity of the dopaminergic system, and vice versa (Calabresi et al., 1997; 
Tzschentke & Schmidt, 2003). In the case for addiction, these two systems converge onto 
medium spiny neurons (MSNs) located in the striatum (Cahill et al., 2014). In these striatal 
MSMs, co-localization of dopamine and glutamate receptors allow multiple possibilities for 
interactions (Cahill et al., 2014).  
Of all the abundant glutamatergic interconnections within the brain, PFC efferents to the 
NAC are thought to be an integral pathway in the reward circuit, especially considering these 
two regions receive dopaminergic afferents from the ventral tegmental area (VTA) (Kalivas 
et al., 2005). The PFC is also the major source of glutamate for the VTA, BLA, and NAC, 
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and is a region that integrates addiction related information and routes it to the NAC for 
subsequent motor output (McFarland & Kalivas, 2001). Thus, glutamate originating in the 
PFC is a key candidate involved in addiction.  
Some of the first evidence to support a role for glutamate in addiction-related 
neuroplasticity was derived from studies of cocaine behavioral sensitization (Pierce et al., 
1998; Carlezon & Nestler, 2002), a phenomenon used to study neuroplasticity associated 
with drug exposure (Robinson & Berridge, 1993; Hyman et al., 2006). Neuropharmacology 
studies show that repeated intraperitoneal (IP) injections of cocaine increases glutamate 
transmission in the NAC in rats that are behaviorally sensitized to cocaine (Pierce et al., 
1996; Cornish & Kalivas, 2001). Cocaine-induced stimulation of glutamate in the mPFC is 
also crucial to the development of behavioral sensitization, as sensitization is associated with 
increased extracellular glutamate in the mPFC as non-sensitized rats did not exhibit these 
changes (Williams & Steketee, 2004). Sensitization is also linked to the impairment of 
metabotropic glutamate receptor (mGlu) 2/3-mediated long-term depression (LTD), as in 
vivo repeated IP cocaine administration impaired mGlu2/3-mediated LTD in bath application 
of different mGlu2/3 agonists to layer 5 pyramidal neurons of the mPFC (Huang et al., 
2007). Glutamate also plays a role in the rewarding effects of cocaine, as blocking it with the 
selective mGlu5 antagonist, MPEP, 10 minutes prior to cocaine exposure decreases 
conditioned place preference (McGeehan & Olive, 2003). More closely related to this 
dissertation, glutamate is thought to be involved in the reinstatement of cocaine-seeking as 
well, as antagonizing AMPA/kainate, NMDA, and mGlu5 all reduce reinstatement 
(Bäckström & Hyytiä, 2006; Bäckström & Hyytiä, 2007; Kumaresan et al., 2009; Novak et 
al., 2010; Wang et al., 2013). 
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1.3.3. Cellular and Molecular Changes During Reinstatement of Cocaine-Seeking 
Efforts to identify the cellular and molecular changes within the mPFC that correlate 
with drug craving have revealed Fos expression, a marker of neuronal activation, is 
increased in the mPFC after re-exposure to cocaine cues (Ciccocioppo et al., 2001; Zavala et 
al., 2007; Kufahl et al., 2009), along with c-fos mRNA levels (Kufahl et al., 2009). Cue-
induced reinstatement is also associated with increased mRNA levels of the plasticity-
associated gene, Arc, in the PL (Zavala et al., 2008). The increased Fos expression in 
response to reinstatement of cocaine-seeking seems to be enduring, as Fos expression is still 
elevated in rats subjected to a test for cue-reinforced cocaine-seeking during protracted 
withdrawal of at least 22 days (Zavala et al., 2007). Along with PFC activation, this region 
experiences alterations of glutamate protein expression in response to drug-seeking.  
Indeed, postsynaptic proteins responsible for trafficking glutamate receptors (i.e., Homer, 
PSD-95, and filamentous (F)-actin) are dysregulated after withdrawal from repeated cocaine 
exposure (Szumlinski et al., 2004; Kalivas & Volkow, 2005). More specifically, Homers and 
PSD-95 are downregulated, while actin levels are increased in either the NAC or in the PFC-
NAC pathway (Szumlinski et al., 2004; Kalivas & Volkow, 2005). Along with altered 
glutamate receptor protein expression, extracellular glutamate in the PFC is dysregulated. 
1.3.4. Microdialysis Studies of Reinstatement of Cocaine-Seeking 
Cocaine induces glutamatergic changes in the NAC. For instance, both chronic non-
contingent cocaine (Bell et al., 2000) and self-administered cocaine increases extracellular 
glutamate (GLUEC) in the NAC (Miguéns et al., 2008; Suto et al., 2010). Increases in GLUEC 
are known to last up to 5 days of extinction training (Miguéns et al., 2008; Suto et al., 2010), 
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as well as during cocaine-induced reinstatement (Miguéns et al., 2008; Berglind et al., 2009; 
Trantham-Davidson et al., 2012). Evidence show that the majority of cocaine-induced 
glutamate increases in the NAC originates from the PFC (Pierce et al., 1998; Park et al., 
2002; McFarland et al., 2003; Kalivas et al., 2005; Ary et al., 2013). For example, ibotenic 
acid lesions into the dPFC prevents cocaine-induced GLUEC increase in the NAC core 
(Pierce et al., 1998), while AAV-mediated increases of Homer2b, but knockdown of 
Homer1c, in the mPFC elicits increased GLUEC in the NAC (Ary et al., 2013). Thus, the 
changes in GLUEC in the NAC are likely due to changes in GLUEC stemming from the PFC.   
These glutamatergic projections are also thought to be important in the reinstatement of 
cocaine-seeking (McFarland et al., 2003; Kalivas et al., 2005; Kalivas & O’Brien, 2008). 
More specifically, cocaine-induced reinstatement elevates GLUEC in the NAC (McFarland et 
al., 2003). This increase in GLUEC is thought to be selective for cocaine-induced 
reinstatement, as a cocaine prime did not increase GLUEC levels in a yoked control group 
and in a food-induced reinstatement study (in which rats were trained to SA food). This 
GLUEC rise exhibited in the NAC is known to originate from the PFC, as inactivation of this 
region via GABAA+B agonists baclofen + muscimol (B/M) blocks the GLUEC rise exhibited 
in the NAC (McFarland et al., 2003). Along with cocaine-induced reinstatement, GLUEC is 
increased in the PFC to NAC pathway, particularly the PL to NAC core, during footshock-
induced reinstatement of cocaine seeking (McFarland et al., 2004). These findings argue that 
an increased excitability of PFC glutamate projections to the NAC may be a critical neural 
substrate driving the propensity of relapse triggers to reinstate drug-seeking behavior in 
animal models. 
1.3.5. Microinjection Studies of Reinstatement of Cocaine-Seeking 
  23 
Further supporting a causal relation between the PFC and reinstatement, many studies 
demonstrate that inactivation of the PFC attenuates reinstatement of cocaine-seeking. For 
instance, cue- and cocaine-induced reinstatement is decreased after mPFC lesions (Fuchs et 
al., 2004; Fuchs et al., 2005). Further, B/M inhibition of the dorsomedial PFC (dmPFC) is 
implicated in footshock-induced reinstatement, while B/M had no effect when infused into 
the vmPFC (McFarland et al., 2004; McFarland & Kalivas, 2001). B/M into the dmPFC, but 
not vmPFC, dose-dependently blocked cocaine-induced reinstatement as well (McFarland & 
Kalivas, 2001). 
 Of the dmPFC subregions targeted in these prior extinction-reinstatement studies, it 
seems that the PL is more critically involved. For example, inactivation of the PL using 
tetrodotoxin (TTX), a sodium channel blocker, blocked footshock-, cue-, and cocaine-
induced reinstatement, while infusion into the IL were ineffective for all three types of 
reinstatement (Capriles et al., 2003; McLaughlin & See, 2003). Inactivation of the PL using 
lidocane is also sufficient to block cue- and cocaine-induced reinstatement (Di Pietro et al., 
2006). In contrast, TTX into the OFC reduced footshock-induced, but not cocaine-induced, 
reinstatement (Capriles et al., 2003).  
Cocaine-associated cues are thought to initiate cocaine-seeking by increasing synaptic 
strength and inducing rapid, transient increases in dendritic spine size in the NAC, as these 
changes were not exhibited in rats similarly trained with sucrose (Gipson et al., 2013), a 
natural reinforcer that is also known to induce seeking (Grimm et al., 2005). Interestingly, 
these changes require neural activity from the PL subregion of the vmPFC, as inactivation of 
this region with B/M infusions both blocks spine head growth along with AMPA to NMDA 
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currents (Gipson 2013), implicating glutamate stemming from the PFC as a main component 
of relapse.  
Indeed, blocking glutamate in the NAC also prevents reinstatement. For example, 
infusion of an AMPA receptor antagonist into the NAC reduces cocaine-induced 
reinstatement (McFarland & Kalivas, 2001). Inhibition of mGlu5 in the NAC core via 
infusion of MTEP prevents cue- and cocaine-induced reinstatement, while administering the 
mGlu5 agonist, CHPG, produces the opposite effect and induces reinstatement of cue- and 
cocaine-induced reinstatement (Wang et al., 2012). This is likely due to blocking the 
glutamate projections stemming from the PFC in the PFC-NAC pathway, based on the afore 
cited work of McFarland and colleagues (2003). B/M inactivation of either the PFC or NAC 
is also reported to block the increase in GLUEC in the NAC and PFC, respectively, along 
with blocking footshock-induced reinstatement (McFarland et al., 2004). BDNF infusion 
into the dmPFC prevents GLUEC increases in the NAC that is normally caused by cocaine-
induced reinstatement, along with drug-seeking behavior (Berglind et al., 2009). 
Along with direct manipulation of glutamate, manipulation of glial glutamate transporter 
(GLT) 1, a sodium-dependent transporter found on astrocytes that is responsible for reuptake 
of most of the glutamate accumulation in the extracellular fluid (Anderson & Swanson, 
2000), impacts cue-induced cocaine reinstatement. Sari and colleagues report that multiple 
IP injections of ceftriaxone, a beta-lactam antibiotic known to increase GLT1 expression, 
attenuates cue-induced cocaine reinstatement, but not cue-induced food relapse (Sari et al., 
2009). Moreover, the attenuation of cue-induced reinstatement is correlated with increases in 
GLT1 expression in the PFC and NAC (Sari et al., 2009). mGlu5 is also known to be 
involved in both cue- and cocaine-induced reinstatement (Kumaresan et al., 2009; Novak et 
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al., 2010; Wang et al., 2013), further solidifying glutamate’s role in relapse. In conclusion, 
cellular, neurochemical, molecular, and pharmacological evidence all point to glutamate 
emanating from the PFC as critical for the reinstatement of cocaine-seeking. But despite this, 
and the fact that the PFC subregions receive large glutamate inputs from various sources (see 
section 1.2.2), the vast majority of the research to date pertaining to corticoaccumbens 
glutamate and addiction has focused on the NAC, with little work focusing on the PFC 
proper. 
1.4 Preclinical Studies of Incubation of Cocaine-Seeking and the Role 
of Glutamate  
1.4.1 Incubation vs. Reinstatement: The Difference Between Paradigms 
Drug craving is a difficult phenomenon to model in rats and can ultimately only be 
inferred through their behavior. As discussed above, the most popular preclinical model of 
craving is the extinction/reinstatement model. However, some have argued that this model 
has low face validity, as rarely do recovering addict undergo explicit extinction training, 
especially in their drug-taking context. Instead, addicts tend to abstain from drug-taking and 
avoid the drug and drug-associated stimuli/environment completely.  
The incubation model mirrors many aspects of the extinction/reinstatement model as it 
involves operant training for drug infusions, but instead of extinction training, the rat is 
given a period of abstinence at the end of which the rat is given a drug-seeking test. This 
abstinence, or withdrawal period, more closely models the human condition. The drug-
seeking test, during which the previously learned operant response still delivers drug-
associated cues but not the drug itself, provides a measure of cue-reinforced drug-seeking, 
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which is thought to more closely mirror craving. Thus, the preclinical model of incubation is 
thought to be a closer model of relapse and drug-craving than the reinstatement model. In 
support of the differences between the models, studies describe molecular differences 
between rats that were left in their home cage, versus rats that received extinction training. 
Zavala and colleagues report increased levels of Fos labeled cells in both the PL and IL 
of rats left in their homecage for 22 days of withdrawal, compared to rats that underwent 
extinction (Zavala et al., 2007). Ghasemzadeh and colleagues report glutamate receptor 
protein changes between three types of post SA withdrawal regimens; extinction training, 
exposure to the operant box, and home cage abstinence regimens all differed in 
redistribution of glutamate receptors in the PFC (Ghasemzadeh et al., 2011). Specifically, 
extinction training was associated with the most plasticity in glutamate receptor expression 
as this group experienced increases in AMPA receptor subunit GluR1, PSD-95, and actin, 
while mGlu5 levels were decreased. Rats exposed to the operant box with retracted levers 
and lights off only experienced decreases in mGlu5 and had increases in actin. The group re-
exposed to the operant chamber did not go through true extinction training per se, and can be 
thought as a partial extinction training as they were re-exposed to the drug-associated 
environment and thus unpaired the context with drug. In contrast, rats left in their homecage 
did not experience any significant changes in glutamate receptors in the PFC. These results 
indicate glutamatergic alterations occur due to extinction training: the more explicit the 
extinction training becomes (i.e., extinction group vs. re-exposure group), the more changes 
in glutamate protein expression (Ghasemzadeh et al., 2011). Similar results were reported to 
occur in the NAC core, as rats that undergo extinction training had increased levels of PSD-
95, Homer 1b/c, and mGlu5, compared to rats kept in their homecage (Knackstedt et al., 
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2010). Together, these studies support the claim that extinction training causes different 
neuronal changes than would plain abstinence before exposure to a drug-seeking test (i.e., 
incubation model), and thus the extinction model would not be the most ideal to compare to 
human drug relapse. Although research on relapse through extinction/reinstatement models 
have vastly enlightened the field, these differences in protein expression prove not all 
information can be carried over and generalized to relapse in humans. Thus, follow up 
studies need to be done on the incubation model. 
1.4.2 Incubation of Cue-Reinforced Drug-Seeking in Rodent Models  
An animal model of incubated craving has been developed (Grimm et al., 2001) that 
serves as a relatively facile model with which to study the time-dependent, as well as 
enduring, changes in the brain that underpin high levels of cue-reinforced drug-seeking 
behavior. In animals, incubation of cue-reinforced craving is modeled by a withdrawal-
dependent increase in the conditioned reinforcing properties of drug-paired discrete stimuli 
assessed in a drug-free state (Pickens et al., 2011), and is reliably replicated across 
procedural variations. At the beginning of my dissertation work, little about the 
underpinning mechanisms of incubated craving was known as it has relatively recent focus 
of intense research. 
Pre-clinical studies on male rats have established incubated drug-seeking, similar to 
humans, involves low responding up to the first 30 days of abstinence, with cocaine-seeking 
peaking from 1-3 months, and tapering off after 6 months (Lu et al., 2004b). This is specific 
to incubated cue-reinforced cocaine-seeking, as rates of cocaine-induced drug-seeking 
remain unchanged over 6 months (Lu et al., 2004b). As baboons trained to self-administer 
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alcohol also exhibit incubated alcohol seeking (Weerts et al., 2006), incubation of drug-
seeking expressed in other species can be assumed to be a generalizable human condition.  
Many factors have the ability to impact incubation of drug-seeking. For example, age is 
an important component as although adult and adolescent rats had similar cocaine SA intake, 
adolescent rats had lower rates of incubated cocaine-seeking, along with cue-induced 
reinstatement, compared to adult rats (Li & Frantz, 2009). Along with age, sex also has an 
impact on incubation. Kerstetter et al. (2008) tested both male and females for incubated 
cocaine-seeking on either 1, 14, 60, or 180 days of withdrawal in a hybrid drug-seeking test 
of 8, 1-hour blocks: the first five 1-hour blocks involved extinction (no cues presented); the 
sixth block involved cue-induced reinstatement (light and tone cues presented); the seventh 
block a saline injection (control for cocaine prime; no cues presented); and lastly, the eighth 
block tested for drug-induced reinstatement using a cocaine prime (no cues presented). 
During extinction, both sexes respond similarly on the active lever at 1, 14, and 60 days 
withdrawal, but as male responding tapered down at 180 days, females still responded 
highly. Interestingly, females in estrus respond considerably more than both males and non-
estrus females during 1, 60, and 180 days of withdrawal. When presented with cocaine-
associated cues, both sexes only reinstated cocaine-seeking behaviors at 60 days of 
withdrawal. For the cocaine prime challenge, estrus females responded almost two-fold 
higher while non-estrus females and males exhibiting similar responding. These results 
suggest that incubation of cocaine-seeking dissipates at 180 days of withdrawal in males but 
not in females, indicating that these changes are more enduring in females, especially 
depending on the reproductive cycle (Kerstetter et al., 2008).  
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Different types of self-administration regimens (LgA [4+ hours] vs. ShA [≤ 3 hours]) are 
known to differentially impact incubation as well. For example, rats trained in 2 hour 
sessions conducted over 11 days did not exhibit increases in CP-AMPA in the NAC core, a 
molecular marker of incubation of craving (Conrad et al., 2008; Ma et al., 2014; Loweth et 
al., 2014), after 40 days of abstinence, but these increase in CP-AMPA were exhibited in rats 
trained in 6 hour sessions given over 10 days (Purgianto et al., 2013). This study also tested 
rats trained in 2 hour sessions over 24 days and rats trained in 6 hour sessions over 24 days 
(first 10 days were 2 hour session after which they were bumped to 6 hours). Only the two 
LgA regimens induced increases of CP-AMPA in MSN of the NAC core. As 6hr/10days and 
2hr/11days rats received about the same number of sessions, and 2hr/24days and 6hr/10days 
had similar overall cocaine infusions, it was concluded that session duration was key in 
inducing increases of CP-AMPA, not the number of sessions or infusions received 
(Purgianto et al., 2013). Yet as this study did not test for incubated cocaine-seeking behavior 
and only incubation of CP-AMPAR, it cannot be said that these shorter regimens do not 
induce incubated cocaine-seeking behaviors.  
Indeed, other studies have found that 2 hour sessions were able to induce incubated 
cocaine-seeking behaviors (Sorge & Stewart 2005; Hollander & Carelli, 2007). Another 
subset of studies provide evidence that 2 hour sessions is enough to induce both incubated 
behavior and CP-AMPAR, as long as rats were given one overnight session at the beginning 
of training (Suska et al., 2013; Lee et al., 2013; Ma et al., 2014). Interestingly, incubation of 
cocaine-seeking along with increased mGlu1 mRNA expression in the PL and IL can be 
induced in mice after only one 6 hour session (43 days withdrawal; Halbout et al., 2014). In 
concert with incubated behavior, time-dependent alterations in NMDA and AMPA 
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regulation were shown to occur: AMPA binding was decreased in the PL and IL at 9WD, 
while NMDA binding was decreased only in the IL at both 9 and 43WD, as measured by 
receptor autoradiography (Halbout et al., 2014).  
A voluntary abstinence paradigm defined as discrete choice between palatable food or 
drug has been established in methamphetamine (meth) incubation studies (Caprioli et al., 
2015; Caprioli et al., 2017; Venniro et al., 2017). Rats in voluntary abstinence are given 
access to 200-minute discrete choice trails between palatable food and meth, whereas forced 
abstinence rats were kept in their homecages (Caprioli et al., 2015). Interestingly, meth-
seeking is reported to be higher after 21 days withdrawal in either voluntary or forced 
abstinence in male and female rats (Venniro et al., 2017). This was not the case with heroin, 
as seeking only incubated at 21 days of withdrawal after forced abstinence in both sexes 
(Venniro et al., 2017). Yet as this paradigm is still new, it has not yet been tested on 
incubation of cocaine-seeking. 
Environmental enrichment, such as group housing, access to running wheels, and novel 
toys, may also influence incubation of drug-seeking, although studies report mixed results. 
One report demonstrates environmental enrichment has no effect on incubated drug-seeking, 
though there was a trend showing it did lower drug-seeking compared to an isolated 
condition (Thiel et al., 2011). On the other hand, Chauvet and colleagues found the opposite 
effect and that environmental enrichment does prevent the development of incubated 
cocaine-seeking, and can even reverse already developed incubation (Chauvet et al., 2012). 
Unfortunately, the effects of environmental enrichment are transient as it has been observed 
that when stopped, its positive effects on drug craving dissipate (Chauvet et al., 2012). 
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1.4.3 Incubation of Drug-Seeking: Other Reinforcers    
Although much less studied in comparison to cocaine, incubation of drug-seeking has 
been found to envelop other types of drugs of abuse (see Table 1). For instance, meth has 
been reported to induce incubated seeking after both ShA and LgA paradigms (Theberge et 
al., 2013; Li et al., 2015; Caprioli et al., 2015; Caprioli et al., 2017; Venniro et al., 2017). A 
subcutaneous (SC) injection of the mGlu2 positive allosteric modulator, ZD8529, decreases 
meth-seeking at 21 but not 1 day of withdraw after either forced or voluntary abstinence 
(Caprioli et al., 2015). Incubation of meth-seeking is associated with increased fos 
expression in the dorsomedial striatum (Caprioli et al., 2017). The CEA is also thought to 
play a role, as B/M inactivation abolishes incubated meth-seeking, but does not have the 
same effect when infused into the BLA, vmPFC, dmPFC, or OFC (Li et al., 2015).  
Heroin is another drug that also induces time-dependent changes of drug-seeking. 
Studies have reported that in both ShA and LgA SA paradigms, heroin is able to elicit time-
dependent changes of drug-seeking (Theberge et al., 2012; Fanous et al., 2012). In both male 
and female rats, incubated heroin-seeking is induced at 21 days withdrawal by forced, but 
not voluntary, abstinence (Venniro et al., 2017). Chronic delivery of naltrexone through an 
osmotic minipump, but not an acute SC injection, decreases incubated seeking (Theberge et 
al., 2013). As inactivation of the OFC with B/M infusion abolishes drug-seeking only at 14 
but not 1 day of withdrawal, and the OFC exhibits increased levels of fos expression only at 
14 day withdrawal, the OFC is thought to play a salient role in this phenomenon (Fanous et 
al., 2012).  
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 Although less studied, the rewarding effects of morphine as measured by conditioned 
place preference also seem to incubate from 1 to 14 days withdrawal, with phospho-
extracellular signal-regulated kinases (p-ERK) and phosopho-cAMP response element-
binding protein (p-CREB) in the CEA thought to be involved as infusion of an extracellular 
signal-regulated kinases (ERK) inhibitor (U0126) decreases their levels, along with 
abolishing morphine-seeking behavior at 14 days withdrawal (Li et al., 2008). As NMDA 
stimulation of ERK and cAMP response element-binding protein (CREB) in the CEA at 1 
day withdrawal was able to increase morphine-seeking behaviors, which was subsequently 
reversed with U0126 infusion, it was concluded that the ERK pathway in the CEA is 
functionally relevant in incubated morphine-seeking (Li et al., 2008).    
More recently, incubation of nicotine-seeking has been reported after nicotine training 
after a ShA SA paradigm (Funk et al., 2016; Markou et al., 2016). Different from other 
drugs of abuse, incubated craving for nicotine peaks earlier at 7 to 14 days of withdrawal, 
tapering off by 21 and 42 days of withdrawal (Markou et al., 2016). Both adult and 
adolescent age range rats develop incubation, with fos expression increased in the dmPFC, 
OFC, NAC core, and CEA, but adult rats seek nicotine at a higher magnitude than 
adolescents (Funk et al., 2016).  
Surprisingly, incubation of alcohol-seeking has not been very well studied in rats. What 
is known is that cue-induced alcohol-seeking has been reported to time-dependently increase 
from 1 to 28 days, with seeking peaking at 56 days withdrawal (Bienkowski et al., 2004). 
Using a hybrid of extinction (no cues; 20 min) and cue-induced reinstatement (cues; last 10 
min) into one 30-min testing session, Bienkowski and colleagues report at 56 days 
withdrawal but not 28 days, alcohol cues are able to rescue previously extinguished seeking-
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behavior learned during extinction (Bienkowski et al., 2004). These results indicate that 
alcohol cues, and perhaps drug cues in general, are extremely powerful during protracted 
abstinence.  
Interestingly, drugs of abuse are not the only reinforcers to cause incubation of craving: 
sucrose also has the power to elicit incubated craving. Rats trained to self-administer sucrose 
exhibit incubated sucrose-seeking, although this behavior is less robust and has a shorter 
duration (only up to 30 day withdrawal) compared to incubated cocaine-seeking (Grimm et 
al., 2003; Grimm et al., 2005; Grimm et al., 2006; Uejima et al., 2007). These two 
phenomena, although behaviorally similar, involves different neuronal mechanisms as there 
were no changes in BDNF levels in the NAC, VTA, or amygdala in incubated sucrose-
seeking rats (Grimm et al., 2003). Though as systemic or direct infusion of LY379268 into 
the CEA attenuates incubated sucrose-seeking, along with incubated cocaine-seeking, it 
seems likely that similar glutamatergic mechanisms are at play in general reward craving 
(Uejima et al., 2007; Lu et al., 2007). Recently, Aoyama and colleagues have reported 
saccharin, a non-caloric sweetener, also has the ability to induce incubated craving (Aoyama 
et al., 2014). Although similar patterns of incubation exists for different types of reinforcers, 
one needs to be careful to make comparisons across reinforces as they all have different 
brain regions involved (see Table 1; Ettenberg et al., 1982; Ettenberg et al., 2009; Badiani et 
al., 2011).  
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1.4.4 Neural Mechanisms of Incubated Cocaine-Seeking  
In regards to preclinical literature on the neural mechanisms of incubation of cocaine 
craving, most studies focus on the NAC, VTA, or the amygdala (Conrad et al., 2008; Chen 
et al., 2008; Lu et al., 2005; Lu et al., 2007; Pelloux et al., 2013; Wolf, 2016), with very little 
investigating the role of the PFC. In the CEA, increased ERK levels are associated with 
incubated drug-seeking (Lu et al., 2005). Inhibition of ERK phosphorylation at protracted 
withdrawal inhibits drug-seeking, while stimulation of ERK phosphorylation during short-
term withdrawal, a time where there is normally low drug-seeking behavior, increases drug-
seeking, further pointing to a causal role of ERK in the CEA during incubation (Lu et al., 
2005). As glutamate is known to activate the ERK pathway, it was hypothesized that this 
neurotransmitter is involved. Consequently, Lu and colleagues tested this theory by infusing 
the mGlu2/3 agonist LY379268 either systemically or into the CEA, reporting that both were 
enough to attenuate incubated cocaine-seeking behavior at protracted withdrawal, but had no 
effect during short-term withdrawal (Lu et al., 2007). Interestingly, there were no changes of 
ERK levels in the BLA, nor did LY379268 infusions into the BLA change incubated 
behavior (Lu et al., 2005; Lu et al., 2007). Yet, disconnection of the BLA to dorsal 
hippocampus inhibits incubated drug-seeking (Wells et al., 2011), suggesting the BLA may 
not play a direct role in incubation. 
In the NAC, important changes in different types of AMPA receptors (AMPAR) are 
known to occur. This receptor class is classified into two different categories: calcium-
permeable (CP) vs. calcium-impermeable (CI). The large majority of AMPARs are CI due to 
the presence of the GluA2 subunit, which possesses a positively charged arginine within the 
channel pore that repels divalent cations (Dingledine et al., 1999). AMPAR lacking the 
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GluA2 subunit are CP and therefore have higher conductance than their CI counterpart, 
enabling them to increase synaptic strength. CP-AMPAR in the NAC core are highly 
implicated in cue-reinforced drug-seeking (Conrad et al., 2008). For instance, CP-AMPAR 
accumulate in the NAC core during protracted withdrawal after exposure to extended-access 
cocaine (Conrad et al., 2008), but not after short-access cocaine (Purgianto et al., 2013). CP-
AMPAR accumulate beginning around 30 days of withdrawal and stay elevated until 70 days 
withdrawal, the latest time point measured to date (Issac et al., 1995). Blockade of CP-
AMPAR with Naspm (Conrad et al., 2008) or indirectly through the upregulation of mGlu1, 
a glutamate receptor known to express long-term depression by removal of CP-AMPARs, 
attenuates incubation of cocaine craving (Loweth et al., 2014). Moreover, inhibiting CP-
AMPAR accumulation in protracted withdrawal prevented incubated drug-seeking, while 
potentiating CP-AMPAR accumulation in short-term withdrawal increased incubated 
behaviors (Loweth et al., 2014), further indicating functional relevance of glutamate 
transmission through CP-AMPAR in incubation of cocaine craving.  
1.4.5 Ventromedial Prefrontal Cortex Glutamatergic Projections and Their Role in 
Incubation    
Exposure to LgA of cocaine has been found to reduce basal levels of glutamate within 
the mPFC, as well as diminishing glutamatergic response to self-administered cocaine (Ben-
Shahar et al., 2012). Along with dysregulation of glutamate during cocaine-taking, glutamate 
transmission is altered in response to cocaine-associated cues. The presentation of drug-
associated cues elicits a surge of extracellular glutamate (GLUEC) within both the cell body 
and terminal regions of the mesocorticolimbic dopamine system, independent of cocaine 
(Suto et al., 2010; Suto et al., 2013; You et al., 2007). Moreover, GLUEC in the NAC is 
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elevated during an extinction session (Suto et al., 2010), along with in the VTA during the 
first extinction session but not the 13th session (You et al., 2007). This fluctuation of GLUEC 
seems to depend on cues that signal the availability of cocaine, as GLUEC decreases in the 
NAC when cues associated with cocaine unavailability are presented, but increases when 
cues associated with cocaine availability are presented (Suto et al., 2013). As yoked cocaine 
controls did not exhibit GLUEC fluctuations, these changes seem to be selective for cocaine 
cues after chronic cocaine exposure (Suto et al., 2013). In parallel, clinical imaging studies 
have shown that drug-associated cues mimic the effects of drug administration on PFC 
activity in drug-experienced individuals (Goldstein & Volkow, 2011), and that metabolic 
activity in the PFC is increased during cue primed craving (Grant et al., 1996).  
One of the first studies on incubation to focus on the PFC proper was done by Koya and 
colleagues. In this study, Koya’s group report a doubling increase in fluorescence staining 
for p-ERK cells, a neural marker for activity, via immunohistochemistry in the vmPFC of 
rats re-exposed to drug-associated context and cues (Koya et al., 2009). As this was not 
found in the dmPFC or in rats not tested for incubated drug-seeking, it suggests that the 
vmPFC is activated during incubation and may be a critical component in this phenomenon. 
In support of a cause and effect relation between craving and the PFC, the same study 
reports inactivation of the vmPFC via microinjection of B/M was able to block incubated 
drug-seeking without having an effect during short-term withdrawal. Activation of this 
region with a GABAa+GABAb antagonist cocktail, bicuculline+saclofen, increased drug-
seeking behavior at short-term withdrawal. These results seem to be cocaine selective, as no 
effects of any kind were exhibited by rats trained to self-administer for sucrose, and also 
region selective, as injection into the dmPFC had no effect on drug-seeking.    
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  Another study on linking incubation to glutamate within the vmPFC found that 
exposure to drug-associated cues after protracted withdrawal from LgA cocaine SA causes a 
reduction of mGlu1/5 in the vmPFC (Ben-Shahar et al., 2013). Importantly, a change in 
mGluR expression is not observed in animals with equivalent cocaine self-administration 
history, but without the opportunity to engage in cocaine-seeking. Thus, reduced vmPFC 
Group 1 mGluR expression is not a mere pharmacodynamic response to cocaine withdrawal, 
but reflects some interaction between withdrawal from cocaine-taking history and re-
exposure to the drug-paired context/cues (Ben-Shahar et al., 2013). Of relevance to behavior, 
the reduction in vmPFC Group1 mGluR expression is correlated with incubated craving. 
Moreover, mimicking (via intra-vmPFC antagonist infusion) and reversing (via intra-vmPFC 
agonist infusion) a deficiency in Group1 mGluR function, promotes and attenuates, 
respectively, cue-maintained drug-seeking in rats (Ben-Shahar et al., 2013). As this receptor 
adaptation does not occur in cocaine-experienced rats that have not been tested for cue-
induced craving, or in rats tested during short-term withdrawal, this indicates that some 
neurochemical event is occurring during the test for cocaine-seeking that is driving mGlu1/5 
receptor expression down. Together, these two studies led me to the conclusion that 
glutamate in the vmPFC may be directly involved in incubated drug-seeking. 
1.5 Specific Aims 
 The studies presented in this dissertation characterize the role of glutamate in the 
vmPFC during the incubation of cocaine-craving in rats using the LgA self-administration 
procedure. The aims of this dissertation were to: 1) clarify the neurochemical changes that 
occur in the vmPFC during a test for drug-seeking during short-term and protracted 
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withdrawal, 2) determine the protein changes that occur in the vmPFC during a test for drug-
seeking during short-term and protracted withdrawal, and 3) directly manipulate endogenous 
glutamate in the two regions of the vmPFC in order to determine its functional relevance for 
incubated drug-seeking. 
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Chapter 2: 
Neurochemical Adaptations in the Ventromedial Prefrontal Cortex 
During Incubation of Cocaine, but Not Sucrose, Craving 
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2.1 Introduction 
Cocaine addiction is a chronic relapsing disorder, characterized by a high propensity for 
relapse even during protracted abstinence. Re-exposure to drug-associated cues and contexts 
are known to trigger drug craving and can even promote relapse (Childress et al., 1999; 
Volkow et al., 1999). The capacity of cues to elicit craving in humans and drug-seeking in 
laboratory animals increases or “incubates” with the passage of time in drug withdrawal 
(Gawin & Kleber, 1986; Grimm et al., 2001). This phenomenon, termed the incubation of 
craving, renders addicts highly susceptible to relapse even following prolonged periods of 
abstinence and has thus become a model of interest. The incubation model serves as a 
relatively facile model with which to study the time-dependent, as well as enduring, changes 
in the brain that underpin high levels of drug-seeking behavior.  
In rodent models, ventromedial aspects of the prefrontal cortex (vmPFC) are known to 
critically regulate the manifestation of incubated drug-craving (Koya et al., 2009; Ma et al., 
2014), yet no studies have investigated the neurochemical anomalies that occur in this area 
during the incubated cocaine craving. Extracellular dopamine and glutamate levels are 
dysregulated in the medial PFC of animals exposed to chronic cocaine use (Ben-Shahar et 
al., 2012), which may be critical in cue-induced drug-seeking. Dopamine itself has not yet 
been implicated in the incubation of craving, but pharmacologically inhibiting dopamine in 
the medial PFC via D1 receptors antagonists attenuates cue-induced reinstatement during 
protracted withdrawal (Ciccocioppo et al., 2001). On the other hand, incubated cocaine-
craving has been correlated with changes in the expression of glutamate receptor-related 
proteins, as well as increased activation of downstream effectors within this subregion (Ben-
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Shahar et al., 2013; Gould et al., 2014; Koya et al., 2009). Indeed, the presentation of drug-
associated cues after chronic cocaine exposure elicits a surge of extracellular glutamate 
within both the cell body and terminal regions of the mesocorticolimbic dopamine system 
(Suto et al., 2010; Suto et al., 2013; You et al., 2007), with decreases in glutamate associated 
with cue-unavailability and increases with cue-availability (Suto et al., 2013). Such findings 
have led us to hypothesize that the incubation of cue-reinforced drug-seeking might reflect 
heightened dopamine and glutamate release within the vmPFC. Using in vivo microdialysis 
procedures, this hypothesis was tested by examining the patterns of extracellular glutamate 
and dopamine within the vmPFC during cue-reinforced responding at early versus later 
withdrawal. To determine the reinforcer-specificity of our observed effects, parallel studies 
were conducted in animals with a history of sucrose-pellet self-administration or in animals 
allowed to respond for the presentation of neutral cues in the absence of any primary 
reinforcer. 
2.2 Materials & Methods  
2.2.1 Subjects, Lever-Response Training, and Surgery  
All procedures were approved by the Institutional Animal Care and Use Committee of 
the University of California Santa Barbara and were consistent with the guidelines of the 
NIH Guide for Care and Use of Laboratory Animals. Male Sprague-Dawley rats (275-325g; 
Charles River Laboratories, Hollister, CA) were pair-housed under standard reverse light-
cycle conditions (lights off: 0700 h), with ad libitum food/water except during lever-
response training, during which food was restricted (16 g/day), 24 h prior to 16-h overnight 
operant sessions (FR1 schedule of reinforcement; 45 mg food pellet; Bio Serv, Frenchtown, 
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NJ; acquisition criterion=100 responses on the active lever/session). Self-administration 
training was conducted in standard 2-lever operant chambers (Med Associates Inc., St. 
Albans, VT). Under ketamine/xylazine anesthesia (respectively 56.25 and 7.5mg/kg, IM; 
2mg/kg banamine analgesic, SC, for post-operative pain), animals were implanted with a 
unilateral microdialysis guide cannula (20-gauge; 8mm long; Synaptech, Marquette, MI) 
aimed 2 mm above the vmPFC (AP: +3.0; ML ± 0.75; DV: –3.0, in mm from Bregma), with 
the placement counterbalanced across hemisphere within each group. Animals slated to self-
administer cocaine were also implanted with a chronic indwelling jugular catheter as 
described previously by our group (see Ben-Shahar et al., 2013; Kersetter et al., 2008). A 
minimum of 4 days was allowed for recovery, with jugular catheter patency maintained by 
daily flushing of sterile heparin/timentin/saline (60 IU/ml and 100 mg/ml, respectively; 
vol=0.1 ml) and confirmed weekly by intravenous infusion of 5 mg/kg brevital (JHP 
Pharmaceuticals, Parsippany, NJ). 
2.2.2 Self-Administration and In Vivo Microdialysis during Cue-Testing Procedures  
Animals were trained to lever-press under an FI20 schedule of reinforcement for 
intravenous cocaine (0.25 mg in 0.1 ml saline infusion; NIDA, Bethesda, MD) or a 45 mg 
sucrose pellet (Bio Serv), with delivery of either reinforcer signaled by a 20-second light-
tone compound stimulus. For control rats, active lever-presses resulted in the light-tone 
stimulus only. Depression of the “inactive lever” had no programmed consequences for any 
group.  During training of the initial cohorts of rats, cocaine animals received an average of 
102 reinforcer-stimulus pairings/6-hour session. Thus, the total maximum number of 
reinforcer-stimulus pairings earned by sucrose-trained animals was capped at 102 to equate 
associative learning across groups. On average, sucrose-trained animals earned 102 
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reinforcers within 3 hours. Thus, control rats were permitted to respond for the neutral cues 
for 3 hours/day. Animals were trained under the above conditions once daily across 10 days, 
and were then left undisturbed in their home cages for either 3 or 30 days, at which time in 
vivo microdialysis procedures were conducted (e.g., Ben-Shahar et al., 2012) during a 2-hour 
cue-reinforced extinction-like drug-seeking test (Extinction Test). For these Extinction 
Tests, active lever-presses resulted in presentation of the light-tone stimulus only. A 
minimum of 4 hours prior to the Extinction Test, a microdialysis probe (8 mm long with 2 
mm membrane; Synaptech) was inserted into the guide cannula, the animals were placed 
into their operant chamber with levers retracted and house lights off, and probes were 
perfused with artificial cerebral spinal fluid (2.0 μl/min; see Ben-Shahar et al., 2012). 
Dialysate collection occurred, in 20-min intervals, for 1 hour prior to the Extinction Test and 
then throughout the duration of the 2-hour Extinction Test session. 10µl of preservative 
(4.76 mM citric acid, 150 mM NaH2PO4, 50 μM EDTA, 3 mM sodium dodecyl sulfate, 
10% methanol (v/v), 15% acetonitrile (v/v), pH 5.6) was added into each dialysate sample to 
prevent oxidation of dopamine. Upon completion of the Extinction Test, probes were 
removed, animals were anesthetized with 4% isoflurane, brains extracted and then stored in 
4% paraformaldehyde for later determination of probe placement within the PFC by standard 
histological methods. Only data from rats exhibiting probe placement within the boundaries 
of the vmPFC (prelimbic and/or infralimbic subregions) were employed in the statistical 
analyses of the data. Dialysate content of dopamine (27µl) and glutamate (20µl) was 
determined for each sample using high pressure liquid chromatography with electrochemical 
detection as described previously (Ben-Shahar et al., 2012).  As the studies of cocaine-
trained, sucrose-trained and control rats were conducted in series, the data were analyzed by 
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ANOVAs separately for each self-administration group, followed by post-hoc tests when 
appropriate.  
2.3. Results  
2.3.1 Self-Administration Training  
Relative to both sucrose-trained and control rats, cocaine-trained animals exhibited the 
highest active-lever responding. However, due to our capping procedure, the number of 
reinforcers/cue presentations earned by cocaine- and sucrose-trained animals was 
comparable (see Table 1). Importantly, the lever-responding, as well as the number of 
reinforcers/cue presentations earned, over the last 3 days of self-administration training was 
equivalent between rats who were slated to be tested at 3 versus 30 day withdrawal, within 
each self-administration group (t-tests, p’s>0.05). 
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 Active Lever Presses Reinforcers/Cue Presentations 
Group 3 days WD 30 days WD 3 days WD 30 days WD 
Neutral 25.3 ± 4.6  27.3 ± 4.7 19.1 ± 3.8 18.5 ± 2.6 
Sucrose 135.4 ± 15.2 142.0 ± 9.2 92.8 ± 6.5 96.4 ± 3.8 
Cocaine 182.0 ± 41.3 146.5 ± 19.6 100.4 ± 6.1 95.6 ± 5.2 
 
Table 2.  Summary of the average number of active lever-presses emitted and number of  
reinforcer/cue presentations earned (± SEMs) over the last 3 days of self-administration training by rats 
reinforced by neutral cues (Control), by sucrose pellets paired with neutral cues (Sucrose) or by cocaine 
infusions paired with neutral cues (Cocaine), slated to be tested for cue-reinforced lever-pressing behavior at 
either 3 or 30 days withdrawal (WD). 
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2.3.2 Neurochemical Correlates of Incubated Cocaine-Seeking  
When tested for cue-reinforced cocaine-seeking at 3 or 30 days withdrawal, cocaine-
trained rats exhibited a withdrawal-dependent increase in active lever-pressing that 
manifested throughout the 2-hour Extinction Test session (Fig.3A) [Withdrawal X Time: 
F(5,80)=3.51, p=0.006; post-hoc t-tests: p’s<0.04]. Cocaine rats responded primarily on the 
active lever and the total number of active lever-presses increased as a function of drug 
withdrawal (Fig.3B) [Lever X Withdrawal: F(1,19)=8.01, p=0.01], indicative of incubated 
cue-reinforced cocaine-seeking.  
Under our conventional microdialysis procedures, no time-dependent differences were 
apparent for baseline extracellular levels of glutamate (t-test, p>0.10), although baseline 
dopamine levels were lower in dialysate collected from Cocaine rats tested at 3 vs. 30 days 
withdrawal [t(16)=4.00, p=0.001] (data not shown). The difference in baseline dopamine 
levels likely reflects two issues: 1) withdrawal from chronic cocaine exposure is correlated 
with decreased basal dopamine in the NAC (Weiss et al., 1992) and PFC (Ben-Shahar et al., 
2012) and 2) individual probe recovery rather than probe localization within PFC as 
histology revealed comparable placements within the prelimbic or infralimbic cortices 
between rats tested at 3 vs. 30 days withdrawal (Fig.3C). Responding for cocaine-associated 
cues elicited dopamine release, but the magnitude of this effect was greater in early vs. later 
withdrawal, most notably during the 2nd hour of testing (Fig.3D) [Withdrawal X Time: 
F(8,136)=4.33, p<0.0001; post-hoc t-tests, p’s<0.05]. The time-dependent reduction in the 
cocaine cue-reactivity of vmPFC dopamine was made even more apparent by an analysis of 
the area under the curve (AUC) for dopamine release during the Extinction Test session 
(Fig.3E) [t(16)= 2.09, p=0.05], however, there was no significant correlation between the 
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magnitude of cue-reinforced dopamine release within vmPFC and cocaine-seeking behavior 
(Fig.3F). However, opposite dopamine (Fig.3D), responding for cocaine-associated cues 
induced a rise in vmPFC glutamate only in later withdrawal, as revealed by analyses of 
either the time-course (Fig.3G) [Withdrawal X Time: F(8,128)=2.11, p=0.04; post-hoc t-
tests: p’s<0.05] (with elevated vmPFC glutamate primarily in the 2nd hour of testing) or the 
magnitude of the response (Fig.3H) [t(16)= 2.90, p=0.01], the latter of which did predict 
cocaine-seeking behavior (Fig.3I). 
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Figure 3.  Summary of the effects of short- (3 day) versus long-term (30 day) withdrawal (WD) from self-
administered cocaine upon cue-reinforced behavior and neurochemistry within the vmPFC when animals were 
tested for 2 h in a cocaine-free state. (A) Time-course of active lever presses (in 20-min bins) emitted by rats 
during the 2-h session, illustrating greater responding throughout testing at 30 vs. 3 days WD, indicative of 
incubation. (B) Comparison of the total number of active and inactive lever-presses at 3 vs. 30 days WD, 
indicating that incubated behavior was goal-directed. (C) Summary of unilateral placements of microdialysis 
probes within the vmPFC. (D-F) Summary of the time-course and area under the curve (AUC) for vmPFC 
extracellular dopamine, illustrating a waning of cue-reinforced dopamine release at 30 days WD and an inverse 
relation between cue-reinforced dopamine release and cocaine-seeking. (G-I) Comparable results for vmPFC 
extracellular levels of glutamate, illustrating an incubation of cue-reinforced glutamate release and a predictive 
relation between cue-reinforced glutamate release and cocaine-seeking. Data represent the means ± SEMs of 
the number of rats indicated in parentheses. *p<0.05 vs. 3 days WD (t-tests).     
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2.3.3 Neurochemical Correlates of Sucrose-Seeking  
When tested for cue-reinforced sucrose-seeking at 3 or 30 days withdrawal, sucrose-
trained rats exhibited a withdrawal-dependent increase in active lever-pressing, which 
manifested only during the 1st 20 min of the 2-hour Extinction Test session (Fig.4A) 
[Withdrawal X Time: F(5,80)=3.24, p=0.01; post-hoc t-tests]. Sucrose-trained rats 
responded selectively on the active lever, but the time-dependent increase in total active 
lever-responding did not reach statistical significance (Fig.4B) [Lever effect: 
F(1,15)=32.17,p>0.001; Lever X Withdrawal, p=0.16], suggesting that reinforcer capping, 
employment of pellets, or allowing ad libitum homecage feeding may blunt incubation (for 
comparison, see e.g. Grimm et al., 2002; 2011).  
Microdialysis probes were localized to both the prelimbic and infralimbic cortices in 
sucrose-trained animals (Fig.4C). However, responding for sucrose-paired cues failed to 
elicit a significant rise in vmPFC dopamine (Fig.4D-E; p’s>0.20) and there was no relation 
between sucrose-seeking and the magnitude of vmPFC dopamine release (Fig.4F). Engaging 
in sucrose-seeking elevated vmPFC extracellular glutamate [Time effect: F(8,104)= 2.28, 
p=0.03]; however, this effect did not vary significantly with sucrose withdrawal (Fig.4G, 
Withdrawal X Time: p=0.10; Fig.4H, t-test: p=0.15) and there was no predictive relation 
between sucrose-seeking and the magnitude of cue-reinforced glutamate release (Fig.4I). 
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Figure 4.  Summary of the effects of short- (3 day) versus long-term (30 day) withdrawal (WD) from self-
administered sucrose upon cue-reinforced behavior and neurochemistry within the vmPFC when animals were 
tested for 2 h in a sucrose-free state. (A) Time-course of active lever presses (in 20-min bins) emitted by rats 
during the 2-h session, illustrating greater responding during the first 20min bin at 3 vs. 30 days WD, indicative 
of a weak incubation. (B) Comparison of the total number of active and inactive lever-presses at 3 vs. 30 days 
WD, which failed to support an incubation of responding. (C) Summary of unilateral placements of 
microdialysis probes within the vmPFC. (D-F) Summary of the time-course and area under the curve (AUC) for 
vmPFC extracellular dopamine, illustrating no cue-reinforced dopamine release and no relation to sucrose-
seeking. (G-I) Comparable results for vmPFC extracellular levels of glutamate, illustrating no cue-reinforced 
glutamate release and no relation to sucrose-seeking. Data represent the means ± SEMs of the number of rats 
indicated in parentheses. *p<0.05 vs. 3 days WD (t-tests). 
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2.3.4 Neurochemical Correlates of Neutral Cue-Seeking 
Control rats exhibited very low and stable rates of lever-pressing for the neutral cues 
across the 2-h Extinction Test session (Fig.5A) [Withdrawal X Time ANOVA, all p’s>0.06]. 
Control rats did selectively allocate their responding towards the “active” lever, most likely 
due to residual learning from lever-response training, however cue-reinforced behavior did 
not vary significantly between the Extinction Tests (Fig.5B) [Lever effect: F(1,15)=30.45, 
p<0.0001; interaction, p>0.07]. The localization of the microdialysis probes within the 
vmPFC of the control rats was comparable to that for the other 2 self-administration groups 
(Fig.5C).  Inspection of Fig.5D and 5E suggested that the opportunity to lever-press for 
neutral cues elevated vmPFC dopamine levels in control rats, particularly at the 3-day time-
point. However, the results of the statistical analyses of these data failed to confirm group 
differences (Fig.5D, Withdrawal X Time ANOVA: p’s>0.08; Fig.5E, t-test: p=0.61) and 
there was no significant relation between cue-reinforced responding for neutral cues and the 
magnitude of dopamine release in control animals (Fig.5F). Lever-pressing for neutral cues 
did elevate vmPFC glutamate levels, but this effect did not vary across Extinction Tests 
[Fig.5G, Time effect: F(8,88)= 3.68, p=0.001; other p’s>0.50; Fig.5H, t-test: p=0.91] and 
did not predict cue-reinforced responding (Fig.5I). These data argue that while the mere 
presentation of neutral cues is reinforcing and can elicit glutamate release within the vmPFC, 
neither behavior nor glutamate release incubates with the passage of time since last cue 
exposure.  
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Figure 5.  Summary of the effects of short- (3 day) versus long-term (30 day) “withdrawal” (WD) from operant 
sessions in which rats responded for neutral cues in the absence of any primary reinforcer upon cue-reinforced 
behavior and neurochemistry within the vmPFC when animals were tested for 2 h. (A) Time-course of active 
lever presses (in 20-min bins) emitted by rats during the 2-h session, illustrating stable, low levels of 
responding at both WD time-points. (B) Comparison of the total number of active and inactive lever-presses at 
3 vs. 30 days WD, which failed to support an incubation of responding. (C) Summary of unilateral placements 
of microdialysis probes within the vmPFC. (D-F) Summary of the time-course and area under the curve (AUC) 
for vmPFC extracellular dopamine, illustrating no cue-reinforced dopamine release and no relation to cue-
seeking.  (G-I) Comparable results for vmPFC extracellular levels of glutamate, illustrating no cue-reinforced 
glutamate release and no relation to cue-seeking. Data represent the means ± SEMs of the number of rats 
indicated in parentheses. *p<0.05 vs. 3 days WD (t-tests). 
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2.4 Discussion 
Neuronal activity within the vmPFC is critical for incubated cocaine-craving as derived 
from studies of animal models (Koya et al., 2009; Ma et al., 2014). Using in vivo 
microdialysis procedures, the present results demonstrate that incubated cocaine-seeking is 
associated with a withdrawal-dependent increase in cue-reinforced glutamate release within 
the vmPFC, concomitant with a waning of dopamine release. To the best of our knowledge, 
this study is the first to examine by in vivo microdialysis the changes in extracellular 
neurotransmitter content within vmPFC as cocaine-free animals engage in cue-reinforced 
responding at different time-points during cocaine withdrawal. The inverse relation between 
vmPFC extracellular dopamine and glutamate levels is contrary to our original hypothesis, 
but is in line with the results from an earlier in vivo microdialysis study of the neurochemical 
effects of cocaine-taking conducted by our group (Ben-Shahar et al., 2012). The 
diametrically opposed cue-reactivity of vmPFC dopamine and glutamate during both early 
and later cocaine withdrawal suggest an antagonistic relation between these two 
neurotransmitter systems in the regulation of cue-reinforced cocaine-seeking, with dopamine 
suppressing and glutamate facilitating behavioral hyper-reactivity to cocaine-paired cues. 
Moreover, these results point to time-dependent dysregulation of the balance between these 
two neurotransmitter systems within the vmPFC as a neurochemical correlate of incubated 
cocaine-craving during protracted withdrawal.   
The precise nature of the dopamine-glutamate interaction at play within the vmPFC to 
regulate cue-reinforced drug-seeking is a topic of current investigation in our laboratory. One 
theory under investigation poses that a time-dependent dysregulation of autoinhibitory 
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mechanisms occur within vmPFC glutamate terminals. The resultant increase in vmPFC 
glutamate hyper-activates corticofugal afferents to the nucleus accumbens (NAC) and/or 
amygdala to increase the incentive salience of drug-associated cues and invigorate drug-
seeking behavior. Supporting excitatory corticofugal drive in craving, cue/imagery-elicited 
craving in human psychomotor stimulant addicts is associated with a coordinate increase in 
metabolic hyperactivity within frontal cortex, striatum and amygdala, which is theorized to 
reflect cue/imagery-elicited hyper-activation of corticofugal afferents (c.f., Kalivas et al., 
2005). More relevant to the incubation of craving phenomenon, (1) optogenetic inhibition of 
vmPFC glutamate afferents to the NAC prevents incubated cocaine-seeking in rats (Ma et 
al., 2014), (2) incubated cocaine-seeking is associated with an incubated or sensitized rise in 
extracellular glutamate within both the vmPFC (Fig.3G,H) and interconnected NAC (Suto et 
al., 2010) and (3) incubated cocaine-seeking can be inhibited by the local infusion of 
mGlu2/3 autoreceptor agonists into the central nucleus of the amygdala (Lu et al., 2007). 
Indeed, mGlu2/3 autoreceptor function is down-regulated within mPFC during protracted 
withdrawal in rats with a history of repeated cocaine injections (Xie & Steketee, 2009).  
Although the present observation of heightened cue-reinforced glutamate release in cocaine-
incubated rats is consistent with a deficit in autoregulatory mechanisms within vmPFC, we 
do not yet know how mGlu2/3 function and expression is impacted within PFC subregions 
by a history of cocaine-taking. While it is tempting to generalize across models, our prior 
immunoblotting research indicates clearly that withdrawal from IV self-administered cocaine 
produces changes in the expression of certain glutamate receptor proteins that are distinct 
from those produced by classical, cocaine sensitization, injection protocols (Ary & 
Szumlinski, 2007; Ben-Shahar et al., 2009, 2013). Moreover, and important for our 
understanding of the neural substrates of incubated drug-craving, the expression pattern of 
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glutamate receptor-related proteins varies with the opportunity to engage in cue-reinforced 
cocaine-seeking behavior during protracted withdrawal (e.g., Ben-Shahar et al., 2013). For 
example, repeated cocaine-injected rodents exhibit increased PFC expression of mGlu1/5 
receptors during protracted withdrawal (Ary & Szumlinski, 2007), while mGlu1/5 receptor 
expression is down-regulated within vmPFC of rats exhibiting incubated cocaine-seeking, 
but not in similarly cocaine-experienced and –withdrawn rats not afforded the opportunity to 
drug-seek (Ben-Shahar et al., 2013). mGlu1/5 receptors desensitize rapidly upon stimulation 
and exhibit slow recovery (e.g., Gereau & Heinemann, 1998), raising the possibility that the 
reduction in vmPFC mGlu1/5 expression observed in incubated cocaine-seeking rats (Ben-
Shahar et al., 2013) results from the incubation of cue-reinforced glutamate release within 
this region. As reduced vmPFC mGlu1/5 function produces cognitive impairments that 
promote cue-reinforced drug-seeking (Ben-Shahar et al., 2013), current research in the 
laboratory seeks to replicate the results of Xie and Steketee (2009) within the context of 
incubated cocaine-seeking to test the hypothesis that incubated cue-reinforced glutamate 
release within vmPFC might reflect a down-regulation of autoreceptor function. 
An alternative, but not necessarily mutually exclusive, theory under investigation relates 
to the observation that dopamine activation of D1 receptors, localized to GABAergic 
interneurons within PFC, inhibits local glutamate release in drug-naïve subjects via GABA-
mediated heteroinhibition of glutamate terminals (e.g., Abekawa et al., 2000). Completely 
hypothetical at this point, we propose that the withdrawal-dependent waning of the cocaine 
cue-reactivity of presumed mesocortical dopamine projections (Fig.3D,E) relieves inhibitory 
GABA tone upon glutamate terminals within vmPFC, thereby disinhibiting local glutamate 
release. The withdrawal-dependent waning of the cue-reactivity of vmPFC dopamine 
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observed herein is a finding in line with clinical evidence for dysregulated frontal cortex 
dopamine in human cocaine addicts (e.g., Kalivas & Volkow, 2011), and is consistent with 
earlier work indicating reduced cocaine-cue reactivity of PFC dopamine in rats with a 
prolonged history of cocaine self-administration (40 days) (Ikegami et al., 2007). The 
molecular underpinnings of the withdrawal-dependent waning of dopamine cue-reactivity 
are unclear at the present time, but could theoretically relate also to anomalies in 
autoinhibitory mechanisms. At present, we surmise that blunted cue-reinforced dopamine 
release reflects a progressive hyper-sensitivity of D3 dopamine autoreceptors on vmPFC 
dopamine terminals.  Although D3 receptor expression is relatively low within PFC, the 
local infusion of D3 receptor antagonists is sufficient to influence different aspects of social 
behavior in rodents, supporting their relevance in motivated behavior (e.g., Watson et al., 
2012). While no study to date has examined directly the role for vmPFC D3 receptors in 
regulating drug-seeking, systemic pretreatment with D3 receptor antagonists or partial 
agonists attenuate drug-seeking behavior under various procedures, including the cue-
induced reinstatement model of relapse (c.f., Keck et al., 2015). Such findings further the 
notion that postsynaptic (presumably D1) receptor stimulation within vmPFC normally 
serves to inhibit drug-seeking behavior, rendering D3 autoreceptors as an intriguing 
candidate for further exploration as a neural substrate of incubated drug-seeking.  
Interestingly, neither dopamine nor glutamate within the vmPFC responded in any 
significant manner in animals trained to respond for sucrose-paired (Fig. 4) or neutral cues 
(Fig. 5). However, compared to prior studies of sucrose reinforcement (e.g., Grimm et al., 
2002), we observed a relatively modest, albeit significant, incubation of sucrose-seeking; 
whether the magnitude of these effects were due to capping of the number of reinforcers, 
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differences in sucrose delivery (pellet vs solution), or ad libitum vs restricted homecage 
feeding is unclear.  Nevertheless, it is clear from the present data that when rats are subjected 
to comparable self-administration training, sucrose-paired cues are less potent than cocaine-
paired cues at eliciting both an incubation of reinforcer-seeking (see also Grimm et al., 2002) 
and dopamine/glutamate release within the vmPFC (Fig. 4). Interestingly, the differential 
impact of time on the ability of cocaine- vs sucrose-paired cues to elicit behavior and 
neurochemical changes are consistent with recent data indicating that cocaine generates 
strong secondary, but not primary, reinforcement relative to sucrose (Turnstall & Kearns, 
2014). Such observations are consistent with previous reports indicating that drugs and 
natural rewards produce different biochemical effects within PFC (e.g., Grimm et al., 2002; 
Koya et al., 2009) and argue that certain biochemical underpinnings of incubated craving 
may be reinforcer-specific. 
2.4.1 Conclusions  
The results of the present study indicate that incubated drug-seeking is associated with a 
time-dependent increase in cue-reinforced glutamate elevations within the vmPFC but a 
blunted dopamine rise within the same region under the same conditions. This 
neurochemical adaptation is not observed in sucrose-seeking animals or cocaine-naïve 
controls responding for cues, arguing that it is a pharmacodynamic response produced by 
withdrawal from cocaine use. These data implicate an incubation of cue-reinforced 
glutamate release and dopamine dysfunction within vmPFC as neurochemical cordons to 
relapse prevention and addiction recovery. If relevant to humans, these results pose 
pharmacotherapeutic strategies that curb corticofugal glutamate responsiveness to cocaine-
paired cues as a viable strategy for facilitating addiction recovery.  
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Chapter 3: 
mGlu2/3 Adaptations in the Ventromedial Prefrontal Cortex During 
Incubation of Cocaine-Seeking 
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3.1 Introduction 
As discussed in the previous two chapters, prefrontal glutamate plays a key role in the 
reinstatement of cocaine-seeking (McFarland et al., 2003; McFarland et al., 2004).  More 
recently, prefrontal glutamate has also been examined within the context of the incubation of 
cocaine-seeking (Shin et al., 2016). The previous chapter established that GLUEC in the 
vmPFC is elevated in response to cocaine-associated cues during protracted withdrawal, but 
not during short-term withdrawal. Furthermore, this increase was selective for cocaine-
associated cues as it was not observed in rats responding for sucrose-associated or neutral 
cues. These results suggest that elevated GLUEC is functionally relevant for incubated 
cocaine-seeking. Thus, the next question addressed in this dissertation is related to 
understanding the mechanism(s) behind this cue-induced augmentation of prefrontal 
glutamate in cocaine-experienced animals.  
Glutamate transmission is partially regulated through mGlu receptors (Conn & Pin, 
1997; Niswender & Pinn, 2010). These receptor types and their role in drug addiction have 
been gaining attention, with particular emphasis on the mGlu1/5 and mGlu2/3 subtypes 
(Kenny & Markou 2004; Moussawi & Kalivas, 2010). Our group has previously shown that 
mGlu1/5 expression in the vmPFC is downregulated after an Extinction Test given during 
long-term withdrawal (Ben-Shahar et al., 2013). However, neuropharmacological studies 
indicated that these receptor subtypes are not involved in cue-induced drug-seeking behavior 
directly, as the local infusion of neither mGlu1/5 agonists nor antagonists was effective at 
reducing lever-pressing during either early or later withdrawal (Ben-Shahar et al., 2013). As 
mGlu1/5 are not directly involved in incubated responding, the next potential glutamate 
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receptor class is the group 2 mGlu receptors. This class of receptors consists of mGlu 
subtypes 2 and 3, whose activation causes a decrease in glutamate signaling via their 
coupling to Gi/o proteins (Conn & Pin, 1997). As they are mainly found presynaptically on 
both neurons as well as on glia, mGlu2/3 function mainly as glutamate autoreceptors (Conn 
& Pin, 1997; Niswender & Pinn, 2010). As incubated drug-seeking is associated with 
increased glutamate, and since there is an abundance of mGlu2/3 in the mPFC (Gu et al., 
2008), we hypothesized that these receptors may be involved in the neural underpinnings of 
incubated craving.  
Indeed, of all the glutamate-targeted addiction treatments used in preclinical studies, 
mGlu2/3 agonists have been the most successful. For example, systemically administered 
mGlu2/3 agonists reduce the reinforcing properties of cocaine, as evidenced by lower 
cocaine self-administration in both rats (Baptista et al., 2004) and squirrel monkeys 
(Adewale et al., 2006). Further, mGlu2/3 agonists reduced cocaine-primed reinstatement of 
drug-seeking in both species (Baptista et al., 2004; Peters and Kalivas, 2006; Adewale et al., 
2006). Systemic mGlu2/3 agonists are also able to block cue-induced reinstatement (Baptista 
et al., 2004; Canella et al., 2013), as well as foot shock-induced reinstatement (Martin 
Fardon & Weiss, 2012) of cocaine-seeking. Of relevance to this chapter, systemic mGlu2/3 
agonist administration impairs incubated cocaine-seeking in rats (Lu et al., 2006). The sites 
of the “anti-addictive” action of mGlu2/3 agonists are thought to lie within the 
mesocorticolimbic system as microinjecting mGlu2/3 agonists into the NAC core (Peters & 
Kalivas, 2006) or CEA (Lu et al., 2006) reduces drug-primed cocaine reinstatement and 
incubation, respectively. These data argue that changes in mGlu2/3 expression or function 
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within the mPFC may contribute not only to drug-seeking behavior, but its incubation during 
protracted withdrawal.   
To date, no study has yet examined the relation between mGlu2/3 expression within the 
mPFC and the manifestation of incubated craving. However, a few studies have examined 
the effects of cocaine withdrawal on mGlu2/3 expression and/or function. Huang et al. 
(2007) reported that, after 5 consecutive days of IP cocaine administration, mGlu2/3-induced 
long-term depression (LTD) is impaired as early as 3WD. In rats treated repeatedly with 
non-contingent cocaine, mGlu2/3 function and signaling is reduced within the mPFC during 
protracted withdrawal (Xi et al., 2002; Bowers et al., 2004; Xie & Steketee, 2009). Fewer 
still have examined the effects of chronic self-administered cocaine on mGlu2/3 function 
within the mPFC, with studies reporting mixed results, likely due to procedural differences. 
For example, mGlu2/3 levels in the mPFC of rats chronically self-administering cocaine 
under either short- or long-access procedures were reported to be no different compared to 
saline-treated controls, when assessed at less than 24 hours withdrawal (Hao et al., 2010). 
On the other hand, Kasanetz et al. state that mGlu2/3 are downregulated in the dorsomedial 
aspect of the PFC after chronic self-administration training in their rat model of cocaine 
addiction (Kasanetz et al., 2013). Cocaine-induced changes in mGlu2/3 expression may be 
subregionally selective within the PFC as a different study established that mGlu2/3 
receptors are up-regulated both in terms of expression and functional coupling in the 
prelimbic cortex (PL) of the vmPFC in rats administered an intravenous bolus of cocaine 
(Allian et al., 2017). However, another study reports mRNA expression levels do not differ 
in the vmPFC between naïve rats or rats exposed to chronic self-administered cocaine, 
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though this is hypothesized by the group to be mainly due to translational and not 
transcriptional regulation (Canella et al., 2013).  
While no cocaine self-administration study has examined for enduring changes in 
mGlu2/3 expresssion and/or function within the PFC, Schwendt et al. (2012) reported a 
reduction in PFC surface expression of mGlu2/3 in rats at 14 WD from self-administered 
methamphetamine (Schwendt et al., 2012). Rats exposed to subcutaneous injections of 
nicotine have shown differential effects on prefrontal expression of mGlu2, depending on 
developmental factors: 35WD from nicotine during adulthood does not alter mGlu2 levels in 
the mPFC, although mGlu2 levels are downregulated during this withdrawal time-point in 
rats exposed to nicotine during adolescence (Counotte et al., 2011). Collectively, these 
studies raise the possibility that a history of cocaine self-administration may also induce 
enduring changes in mGlu2/3 function/expression that relate to incubated craving.  
The evidence presented above supports the notion that mGlu2/3 plays an important role 
in cocaine addiction, yet these receptors have not yet been studied within the context of 
incubated cocaine-seeking. The present chapter aims to characterize the relation between 
incubated cocaine-seeking and mGlu2/3 protein levels in the vmPFC via immunoblotting 
procedures. As an increase in GLUEC is observed during protracted withdrawal, it is 
hypothesized that mGlu2/3 autoreceptor levels would be decreased after both 3WD and 
30WD from chronic cocaine exposure, but to a greater extent during 30WD, corresponding 
with the manifestation of intensified drug-seeking.  
3.2 Materials & Methods 
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3.2.1 Subjects and Cocaine Self-Administration Procedures 
As described in Chapter 2, rats were trained to self-administer cocaine 
(0.25mg/kg/infusion) on an LgA paradigm (6hr/day) for 10 consecutive days. At either 3 or 
30WD, rats underwent a 2 hour Extinction Test in concert with microdialysis procedures on 
one hemisphere of the brain (see Section 2.2 for detailed procedures).  
3.2.2 Western Immunoblotting  
Two experiments were conducted in the same cohort of rats in order to minimize the 
number of animal subjects needed to run experiments in Chapter 2 and 3. The hemisphere 
free of microdialysis cannula implantation of rats used in Chapter 2 (see Section 2.2) was 
immediately dissected after the completion of the Extinction Test in order to perform 
Western blotting procedures. Rats were lightly anesthetized with 4% isoflurane (~5 minute 
exposure) and the vmPFC was dissected out over ice. Tissue was immediately stored in dry 
ice in the -80°C freezer until processing.  
As previously described by our group (Obara et al., 2009; Ben-Shahar et al., 2013), brain 
tissue was homogenized in a medium consisting of 0.32 M sucrose, 2 mM EDTA, 1% w/v 
sodium dodecyl sulfate, 50 µM phenyl methyl sulfonyl fluoride, 1 µg/ml leupeptin (pH=7.2), 
1 mM sodium fluoride, 50 mM sodium pyrophosphate, 20 mM 2-glycerol phosphate, 1 nM 
p-nitrophenyl phosphate, 1 mM orthovanadate, and 2 µM microcystin LR, in order to inhibit 
phosphatase activity. Samples were subjected to centrifugation at 10,000 X g for 20 minutes. 
Protein content was determined using Bio-Rad DC protein assay (Bio-Rad, Hercules, CA). 
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Protein samples (15 µg/lane) were subjected to SDS-polyacrylamide gel electrophoresis, 
reduced, on Tris-acetate gradient gels (3-8%; Invitrogen, Carlsbad, CA). 3 µL of Odyssey 
protein molecular weight marker (LiCor, Lincoln, NE) consisting of 10-250 kDa markers 
was also loaded in order to visualize weight of proteins detected. Proteins were wet 
transferred onto hydrophobic polyvinylidene difluoride membranes (Immobilon-FL, 
Millipore, Billerica, MA) then pre-blocked with phosphate-buffered saline containing 0.1% 
(v/v) Tween-20 and nonfat dried milk powder for no less than 2 hours at room temperature, 
followed by overnight incubation with primary antibody. Anti-mGlu2/3 rabbit polyclongal 
(1:1000; Upstate Cell Signaling Solutions; Lake Placid, NY) was used as the primary 
antibody for mGlu2/3 receptor detection. For all gels, anti-calnexin rabbit polyclonal 
primary antibody (1:1000 dilution; Enzo Life Sciences; Farmingdale, NY) was used to 
confirm even protein loading and transfer. As calnexin is also a common house-keeping 
gene, it was also used as a reference protein for comparison, as discussed later.  
After primary incubation, membranes were washed 3x for 5 minutes then incubated with 
fluorescent secondary IRDye 800CW goat anti-rabbit (1:10,000 dilution; LiCor) for 90 
minutes at room temperature. As the secondary antibody is light sensitive, each step from 
here on forth was light protected. Membranes were again washed 3x for 5 minutes, then 
placed into an Odessey Fc (LiCor) in order to visual florescent imaging of immunoreactive 
bands, and also to digitally analyze said bands. Immunoreactivity of each protein band of 
interest was normalized to their respective calnexin band, with the relative change in protein 
immunoreactivity expressed as a percent of the average reactivity of neutral cue group on the 
corresponding gel (n=3-4/gel).  
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3.2.3 Statistical Analyses  
As the main goal of this experiment was to compare protein levels of rats trained to lever 
press for cocaine (COC), sucrose (SUC), or neutral light and tone cues (NEUT) at 3 and 
30WD, each gel was run separately by Withdrawal group. Although conventional methods 
for testing for incubation would be to compare the immunoreactive signal at 3 and 30WD, 
the present study had 3 treatment groups for each withdrawal period. Using gels with the 
maximum number of lanes possible (15), it was not feasible to run 6 different treatment 
groups on one gel as an n=3-4 for each treatment group is needed to reliably run statistical 
analyses. Thus, we opted to compare across samples from each of the three treatment groups 
(COC, SUC, or NEUT), separately for each withdrawal period. The data for 3 or 30WD 
were analyzed separately using an univariate ANOVA across the three different treatment 
group. α= 0.05 for all analyses. 
3.3 Results 
3.3.1 Cue-Reinforced Cocaine-Seeking Does Not Affect mGlu2/3 Expression in the 
vmPFC at Either Short or Long-Term Withdrawal  
There were no differences between the SUC and NEUT groups at either short [t(24)= 
1.07, p=0.30] or long-term [t(21)=0.79, p=0.44] withdrawal. Thus, the data from these two 
control groups were combined together into a control group to increase the statistical power 
of the analysis. When compared to the control group, exposure to the cocaine-associated 
cues did not affect mGlu2/3 levels within the vmPFC at either short [F(1,35)= 0.87, p=0.36; 
Figure 6] or long term [F(1,31)= 0.7, p=0.41; Figure 7] withdrawal. COC rats tested during 
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3WD exhibited an approximate 40% reduction in mGlu2/3 [M= 100, SEM= 23.37], 
compared to 3WD control animals [M= 65.21, SEM= 14.27], however, this change was not 
statistically significant.  
3.3.2 Correlational Analysis of the Relation Between vmPFC mGlu2/3 Levels and Active 
Lever-Pressing 
When all animals were considered, there was no relation between mGlu2/3 levels within 
vmPFC and the number of active lever-presses emitted by the rats during cue-testing in 
Chapter 2 (r= -0.20, p= 0.19, N= 44). When only cocaine-experienced animals were 
considered, the correlation between mGlu2/3 levels and lever-pressing was stronger, but not 
statistically significant (r= -0.39, p= 0.13, N= 16; Figure 8). In contrast, there was absolutely 
no correlation between mGlu2/3 levels and responding exhibited by control animals  
(r= 0.01, p= 0.95, N= 28; Figure 8). When examining the data from the animals tested at 
3WD, there was also no significant correlation between mGlu2/3 levels and lever-presssing 
(r= -0.06, p= 0.79, N= 22) nor was there a significant correlation between these variables for 
animals tested at 30WD (r= -0.20, p= 0.36, N= 22). 
3.3.3 Correlational Analysis of the Relation Between vmPFC mGlu2/3 Levels and AUC 
for GLUEC 
Given that mGlu2/3 receptors regulate GLUEC, the relationship between vmPFC 
mGlu2/3 expression and the AUC for GLUEC observed in Chapter 2 was also determined.  
When all animals were considered, there was no correlation between mGlu2/3 levels within 
vmPFC and the AUC for GLUEC, when measured from the opposite hemisphere (r= 0.08, p= 
0.61, N= 44; data not shown). The correlation did not improve when only COC animals were 
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considered (r= 0.07, p= 0.80, N= 16) or when only the collapsed controls (SUC + NEUT) 
were considered (r= 0.09, p= 0.64, N= 28). When examining the rats tested at 3WD, there 
was no relation between vmPFC mGlu2/3 levels and GLUEC (r= -0.09, p= 0.68, N= 22; data 
not shown). However, for the rats tested at 30 WD, the correlation between mGlu2/3 levels 
and GLUEC was shy of significance (r= 0.37, p= 0.09, N= 22; data not shown), but, 
unexpectedly, the relationship was positive and not negative, as would be expected given the 
autoreceptor function of mGlu2/3.  
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Figure 6. vmPFC immunoblotting results. Rats were trained to self-administer  either cocaine (COC) or sucrose 
(SUC) for for 10 days, with each reinforcer delivery associated with a light/tone cue. Cue-neutral (NEUT) rats 
were placed into the self-administration chambers daily but their lever-pressing resulted in no reinforcer 
delivery.  Animals then experienced a 2-hr extinction-like test of cue-induced reinforcer-seeking, at 3 days 
withdrawal (WD). (A) No group differences were observed for calnexin (left) or mGlu2/3 levels (right) within 
the mPFC. (B) Representative immunoblots for calnexin and mGlu2/3from NEUT, SUC, and COC treatment 
conditions at 3 WD.   
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Figure 7. vmPFC immunoblotting results. Rats self-administered for either cocaine (COC), sucrose (SUC), or 
neutral (NEUT) rewards for 6hr/10days then experienced a 2hr cue-induced extinction-like seeking test after 30 
days withdrawal (WD) exhibited no change in mGlu2/3 levels. (A) The optical density for calnexin (CAL), a 
reference protein to control for differences in gel loading, or mGlu2/3. (B) Representative immunoblots from 
NEUT, SUC, and COC treatment conditions.   
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Figure 8. Pearson’s Correlations conducted on the data for mGlu2/3 levels and active lever-presses during a 
2hr cue-induced extinction-like seeking test at either 3 or 30 days withdrawal (WD). There was no correlation 
between treatment group [neutral (NEUT), sucrose (SUC), or cocaine (COC)] and active lever-presses at either 
WD time point. All p’s<0.13.  
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3.4 Discussion 
As 30WD is a time period where GLUEC is elevated in response to cue-induced drug-
seeking (Shin et al., 2016), it was originally hypothesized that mGlu2/3 expression would be 
downregulated at this time, and to a lesser extent, at 3WD. However, cue-induced cocaine-
seeking did not affect mGlu2/3 levels in the vmPFC at either short- or long-term withdrawal, 
as compared to sucrose-seeking rats or rats lever pressing for neutral cues. In addition, there 
was no correlation between vmPFC mGlu2/3 levels and active lever-pressing at either 3 or 
30WD. There was also no correlation between mGlu2/3 expression and AUC GLUEC at 
either withdrawal time points. The present findings are consistent with some of the existing 
literature pertaining to the effects of cocaine self-administration upon mGlu2/3 expression, 
which also failed to observe any effects upon mGlu2/3 total expression within mPFC (Hao 
et al., 2010). Taken together, these data argue little relationship between the manifestation of 
incubated cocaine-seeking, GLUEC, and mGlu2/3 expression within mPFC. 
The present results do not negate the possibility that mGlu2/3 within other regions may 
contribute to this phenomenon. To reiterate, mGlu2/3 has reduced receptor function and is 
downregulated in many brain regions such as the PFC and NAC after exposure to self-
administered cocaine (Kasanetz et al., 2013; Moussawi & Kalivas, 2010). As systemic 
mGlu2/3 agonists impair incubated cocaine-seeking (Lu et al., 2007), it is plausible that 
along with a loss of function after exposure to cocaine, these receptors also downregulate 
following protracted withdrawal from chronic cocaine and their function is rescued by 
mGlu2/3 agonists. One region in which mGlu2/3 appears to contribute to incubated drug-
seeking is the CEA, as microinjecting the mGlu2/3 agonist LY379268 directly into the CEA 
decreases incubated drug-seeking (Lu et al., 2007). In addition, mGlu2/3 in the CEA lose 
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their ability to modulate synaptic transmission after chronic IP cocaine treatment, with these 
decreases persisting for least 7 days withdrawal (Neugebauer et al., 2008). Interestingly, 
synaptic transmission is enhanced in the CEA (Neugebauer et al., 2000) after cocaine 
treatment, suggesting that the downregulation of mGlu2/3, and their loss of ability to control 
synaptic transmission, may be a driving factor behind the propensity for relapse. As PFC 
synaptic transmission is also enhanced after cocaine treatment (Luís et al., 2016), and much 
evidence exists in support of a cocaine-induced mGlu2/3 reduction in the PFC (Baptista et 
al., 2004; Peters & Kalivas 2006; Lu et al., 2007), it was surprising that the present study did 
not find any evidence to support the claim that mGlu2/3 in the PFC also contributes to 
incubated drug-seeking.  
The lack of any time-dependent change in mGlu2/3 expression, coupled with the failure 
to observe a correlation between mGlu2/3 levels and GLUEC, may indicate that incubation 
and elevated GLUEC exhibited during protracted withdrawal are not due to a downregulation 
of mGlu2/3 in the vmPFC. Although the present findings argue that mGlu2/3 in the vmPFC 
is not directly involved in incubation, other studies have found the opposite. For example, a 
recently published study found that mGlu2 knock out (KO) mutant rats show reduced 
instances of cue-induced drug-seeking at 2, 7, and 14WD (Yang et al., 2017), suggesting that 
mGlu2 is involved in craving during withdrawal. More specifically, this study showed that 
mGlu2 KO rats have reduced reward efficacy of cocaine, show faster extinction, and have 
lower rates of cocaine-induced reinstatement. Hence, it is plausible that these receptors are 
indeed involved in incubated drug-seeking, as well as cue-induced reinstatement as many 
studies indicate (Baptista et al., 2004; Peters & Kalivas 2006; Lu et al., 2007), and the 
present study did not find mGlu2/3 involvement due to study limitations. 
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First and foremost, all rats examined in this experiment underwent a 5-hr microdialysis 
session on the contralateral hemisphere (see Section 2.2 for more details). Thus, there is the 
possibility that mGlu2/3 level detection was influenced by this microdialysis procedure. 
Another potential contributing factor to our negative immunoblotting results might relate to 
the experimenter-related differences in the free-hand dissection of the mPFC as two 
experimenter were involved in this process and I was naïve to brain dissection procedures at 
the time of tissue collection. 
Another limitation of the present study relates to the specific immunoblotting technique 
employed.  For one, this study examined only total protein expression and not cell surface 
expression. Therefore, it is possible that although we did not detect overall changes in 
mGlu2/3 protein levels during drug-seeking, the cell surface expression of mGlu2/3 function 
may still have been altered, but any such effect could be masked by inclusion of 
cytosolic/intracellularly retained proteins.  Indeed, studies have found that mRNA 
expression for mGlu2’s are not altered, but the level of functional mGlu2 are dysregulated in 
both cocaine- (Canella et al., 2013) and nicotine-treated animals (Counotte et al., 2011), 
arguing that withdrawal somehow changes mGlu2/3 function but not expression, per se. 
Lastly, the present study unfortunately did not examine the active, dimer form of mGlu2/3 
(Pin et al., 2003) and instead examined the monomer form of mGlu2/3 at 100-110kDa due to 
the gel employed. In addition, mGlu2/3 are notorious for being hard to detect due to high 
levels of background staining, which prevented me from being able to examine the dimer 
form at 200-10kDa. Thus, future work should focus on refining our immunoblotting 
approaches to facilitate detection of both the monomer and dimer forms of mGlu2/3.  
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Lastly, null results may have been due to the fact that the vmPFC can be subdivided into 
two cortical subareas involved in different aspects in drug-seeking: the prelimbic and 
infralimbic cortices (respectively, PL and IL). Although juxtaposed, the PL and IL oppositely 
control aspects of drug-seeking, particularly during protracted withdrawal. Specifically, 
neuropharmacological (Koya et al., 2009; Pelloux et al., 2013) and optogenetic (Stefanik et 
al., 2013; Ma et al., 2014; Stefanik et al., 2015) evidence points to PL involvement in 
driving drug-seeking, as its inactivation prevents incubated drug-seeking. In contrast, IL 
activity inhibits aspects of drug-seeking in the extinction-reinstatement model of relapse 
(Peters et al., 2008; LaLumiere et al., 2012). Along with opposing roles in regulating drug-
seeking, the glutamatergic projections from the PL and IL undergo differential remodeling 
based on circuitry as well (Ma et al., 2014).  
As briefly discussed in Section 1.4.2., optogenetically reversing the maturation of silent 
synapses – a phenomenon linked to incubated drug-seeking – in the IL-NAC projections 
attenuates incubated cocaine-seeking, while reversing maturation in the PL-NAC projections 
potentiates incubated cocaine-seeking (Ma et al., 2014). In this influential study, Ma and 
colleagues report that silent synapses are generated in the projections from both the PL and 
IL to the NAC core and shell, respectively, following cocaine self-administration, with these 
synapses maturing during protracted withdrawal in both cortical projections (Ma et al., 
2014). However, the time-dependent unsilencing of synapses in the two opposing pathways 
are done distinctively. PL-NAC projections involve the recruitment of CI-AMPAR within 
the NAC core as it is blocked by a non-selective AMPAR antagonist, but not a GluA2-
selective antagonist. In contrast, the time-dependent unsilencing of synapses within the IL-
NAC shell projections are due to CP-AMPAR insertion within the NAC shell, as the 
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unsilencing can be reversed by both selective and non-selective GluA2-containing AMPAR 
antagonists.  
Just as the PL and IL undergo differential remodeling, mGlu2/3 may be regulated 
differently subregionally. Indeed, Meinhardt et al. has reported subregion-selective 
regulation of mGlu2/3 during protracted alcohol withdrawal in alcohol-dependent rats, 
which exhibit a persistent (at least 21 days) reduction in the expression of the GRM2 
transcript encoding mGlu2 that was selective for the IL, but not the PL of the vmPFC 
(Meinhardt et al., 2013). As the goal of the present study was to obtain a protein correlate to 
relate directly to results of Experiment 1 (Chapter 2), the entire vmPFC was examined to 
stay consistent with Experiment 1 as it was not able to distinguish dialysate origin between 
subregions. It is therefore my hypothesis that subregion-specific changes in mGlu2/3 may 
have gone unnoticed as the entire vmPFC was taken. As it is now clear that the two 
subregions of the vmPFC differ in remodeling, mGlu2/3 regulation, and their role in drug-
seeking, studies moving forward will delineate between the two subregions. 
Future studies will need to assess the impact of incubated drug-seeking on the expression 
of mGlu2/3 without the confounds of microdialysis procedures. The expression of mGlu2/3 
would ideally be measured following subcellular fractionation or cell-surface biotinylation 
assays to index for changes in the amount of cell-surface receptors.  Further, examination of 
the relative expression of the dimer versus monomer forms of mGlu2/3 would also provide 
important information regarding the effects of cocaine-taking and withdrawal upon the 
amount of active receptor. Finally, GTPϒS binding assays and/or neuropharmacological 
approaches could be employed to index more directly changes in mGlu2/3 function and the 
functional relevant of this receptor in incubated cocaine-seeking. For all of these assays, 
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future studies should assess the differences of mGlu2/3 levels in the PL vs. the IL, given that 
they play opposing roles in regulating incubated drug-seeking and relapse in animal models 
and given the evidence that different glutamatergic adaptations can occur within the 
projections from these vmPFC subregions. To this end, the next chapter aims to examine the 
functional relevance of endogenous glutamate within the PL versus IL, in cue-induced 
cocaine-seeking and its incubation during protracted withdrawal.  
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Chapter 4: 
Endogenous Glutamate Within the Prelimbic and Infralimbic Cortices 
Oppositely Regulate the Incubation of Cocaine-Seeking in Rats 
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4.1 Introduction  
Drug-associated cues elicit intense drug-craving (Childress et al., 1993; Goldstein et al., 
2011), and this ability strengthens during prolonged abstinence (Tran-Nguyen et al., 1998; 
Grimm et al., 2001; Lu et al., 2004; Pickens et al., 2011). In human cocaine addicts, craving 
in response to drug-associated cues presents itself in an inverse-U shape curve over time 
(Gawin & Kleber, 1986; Parvaz et al., 2016). This phenomenon, termed the incubation of 
craving (Grimm et al., 2001; Lu et al., 2004; Pickens et al., 2011), also manifests with other 
types of drugs of abuse (Nicotine: Bedi et al., 2011; Meth: Wang et al., 2013; Alcohol: Li et 
al., 2014) and may help elucidate a period of time where addicts are most vulnerable to cue-
induced relapse. The functional neuroanatomy involved in the incubation of cocaine craving 
remains to be fully elucidated. However, it likely relates to neuroadaptations within the 
prefrontal cortex (PFC), based on evidence that cocaine abusers consistently exhibit 
increased metabolic indices of hyperactivity within this region during cue-induced craving 
(Grant et al., 1996; Garavan et al., 2000; Bonson et al., 2002).  
In laboratory rodents, the incubation of cue-induced craving is modeled by a withdrawal-
dependent increase in the conditioned reinforcing properties of drug-paired discrete stimuli, 
typically assessed when the animal is in a drug-free state (Grimm et al., 2001; Pickens et al., 
2011). Indeed, evidence from such preclinical studies also implicates the PFC, notably its 
more ventromedial aspects (vmPFC), as underpinning incubated craving. For one, 
neuropharmacological inactivation of the vmPFC, via infusion of a GABA agonist cocktail, 
decreases incubated drug-seeking (Koya et al., 2009). Cues signaling cocaine availability 
promote cocaine-seeking by elevating glutamatergic transmission in the nucleus accumbens 
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(Suto et al., 2013), a major downstream projection of the vmPFC. Further, the expression of 
incubated cocaine-seeking is positively correlated with higher expression of neural activity 
markers within the vmPFC, such as p-ERK (Koya et al., 2009) and p-PKCε (Miller et al., 
2016), as well as increases in extracellular glutamate during incubated drug-seeking (Shin et 
al., 2016). This cue-reinforced rise in extracellular glutamate in the vmPFC appears to be 
cocaine-selective as it is not apparent in sucrose- or neutral cue-reinforced rats (Shin et al., 
2016). Put together, these data have led to the hypothesis that endogenous glutamate from 
the vmPFC may be a driving factor in incubated drug-seeking.   
The vmPFC is divided into two subregions: the prelimbic and infralimbic cortices 
(respectively, PL and IL). Although some neuroanatomical overlap exists with respect to 
their innervation of nucleus accumbens (NAc) subregions, the PL mainly projects to the 
NAc core, while the IL mainly projects to the NAc shell (Vertes et al., 2004). Although 
adjacent to each other, these two regions oppositely control aspects of drug-seeking, 
particularly during protracted withdrawal. Specifically, neuropharmacological (Pelloux et al., 
2013) and optogenetic (Stefanik et al., 2013; Ma et al., 2014; Stefanik et al., 2015) evidence 
argues that PL activity drives drug-seeking behavior. In contrast, IL activity inhibits aspects 
of cocaine-seeking in the extinction-reinstatement model of relapse (Peters et al., 2008; 
LaLumiere et al., 2012) and also during incubated cocaine-seeking (Ma et al., 2014). 
Likewise, 3,4-methylenedioxymethamphetamine (MDMA) reinstatement studies also point 
to dichotomous roles for the IL and PL in regulating drug-seeking behavior, as inactivation 
of the PL, but not the IL, completely blocked cue-induced reinstatement of MDMA-seeking 
behavior (Ball et al., 2012). Further, optogenetic and electrophysiological studies indicate 
that AMPA receptors in the NAc undergo differential remodeling during protracted 
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withdrawal from cocaine self-administration to influence the incubation process (Conrad et 
al., 2008; Ma et al., 2014). More specifically, optogenetically reversing the maturation of 
silent glutamatergic synapses – a phenomenon linked to incubated drug-seeking – in IL-
NAC projections attenuates incubated cocaine-seeking, while reversing maturation in the 
PL-NAC projections potentiates incubated cocaine-seeking (Ma et al., 2014). As optogenetic 
approaches cannot inform as to the biochemical bases of incubation, we sought to delineate 
the relative role for glutamate within the PL versus IL in the incubation of cocaine-seeking 
using bidirectional neuropharmacological approaches. More specifically, endogenous 
glutamate within each vmPFC subregion was raised using the non-selective excitatory amino 
acid transporter (EAAT) reuptake inhibitor DL-threo-β-benzyloxyaspartate (TBOA) and 
lowered using the mGlu2/3 autoreceptor agonist LY379268. As the PL putatively drives 
drug-seeking behavior, we hypothesized that mimicking the cue-reinforced increase in 
glutamate (Shin et al., 2016) within this subregion upon TBOA infusion would augment 
incubated drug-seeking behavior, while inhibiting cue-reinforced glutamate release with 
LY379268 would produce the opposite effect. Conversely, as IL activity tends to inhibit 
drug-seeking, we hypothesized that increasing and lowering glutamate within this more 
ventral subregion would attenuate and promote incubated drug-seeking, respectively.  
4.2. Material and Methods 
4.2.1 Subjects  
Male Sprague-Dawley (N= 160) rats weighing 275-325g were obtained from Charles 
River Laboratories (Hollister, CA, USA) and allowed 2 days to acclimate to the colony. Rats 
were pair-housed in a colony room that was temperature (25°C) and humidity (71%) 
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controlled under a 12-hr reverse light cycle (lights off: 0700 h). Food and water was 
available ad libitum except during food training. All experimental protocols were consistent 
with the National Institute of Health Guide for Care and Use of Laboratory Animals and 
approved by the University of California, Santa Barbara, Institutional Animal Care and Use 
Committee.  
4.2.2 Lever-Response Training  
To be consistent with the procedures employed in our prior microdialysis study (Shin et 
al., 2016), rats were food-deprived to 16 grams/day in order to promote lever-response 
training. Rats were placed into sound-attenuated operant-conditioning chambers (30x20x24 
cm; Med Associates Inc., St. Albans, VT) for 16-h overnight. Each chamber contained two 
retractable levers, a stimulus light above each lever, a food trough between the levers, a 
house light on the wall opposite the levers, and a speaker connected to a tone generator 
(ANL-926, Med Associates). A lever press on the active lever resulted in the delivery of a 45 
mg food pellet (Bio Serv, Frenchtown, NJ), along with a 1-sec presentation of light above 
the active lever. Once lever-response training was completed (acquisition criterion= 100 
responses per active lever/session), rats were taken off food restriction, then slated to 
undergo surgery.  
4.2.3 Jugular Implantation and vmPFC Cannulae Surgeries  
 Rats were anesthetized with a ketamine/xylazine cocktail (56.25 and 7.5mg/kg, 
respectively, intramuscular) and then implanted with a chronic indwelling catheter into the 
right jugular vein, as previously described by our group (Ben-Shahar et al., 2013; Shin et al., 
2016; Miller et al., 2016). Each catheter was comprised of Silastic tubing (13 cm long; 0.3 
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mm inner diameter, 0.64 mm outer diameter; Dow Corning, Midland, MI), attached to a 
threaded 22 gauge metal guide cannula (Plastics One, Roanoke, VA) that was cemented to a 
small square of polypropylene mesh (Bard Mesh, C.R. Bard, Cranston, RI), which ensured 
adherence to tissue around the animal’s back.  
Immediately following intravenous catheter implantation, rats were transferred to a 
stereotaxic apparatus and implanted with a bilateral guide cannula (22 gauge, 1 mm c/c, 
13mm long; Plastics One) aimed 2 mm above either the PL (AP: +3 mm; ML: ±1.0; DV: -
1.5mm) or the IL (AP: +3 mm; ML: ±1.0; DV: -3 mm; Paxinos & Watson, 2007). Four 
small stainless steel screws and cranioplastic cement secured the guide cannulae to the skull. 
Stylets (Plastics One) were placed into each cannula in order to prevent occlusion.  
Rats were given banamine (2 mg/kg; non-opiate analgesic; subcutaneous) to reduce 
postsurgical pain before surgeries and for 2 days post-surgery. On the subsequent days until 
the end of the experiment, rats were flushed intravenously with 0.1 ml of sterile gentamycin 
(2 mg/kg) and heparin+cefazolin (60 IU/ml and 1 mg/ml, respectively) in order to maintain 
catheter patency. All catheters were tested every week for patency using sodium brevitol (5 
mg/kg, intravenous; JHP Pharmaceuticals, Parsippany, NJ, USA). 
4.2.4 Self-Administration  
 Allowing a minimum of 5 days for recovery after surgeries, rats were allowed to self-
administer cocaine (0.25 mg/0.1 ml/infusion; Sigma-Aldrich, St. Louis, MO) on a fixed ratio 
1 schedule of reinforcement, 6 h/day, for 10 consecutive days. This was done in the same 
operant chambers as lever-response training described above. Depression of the active lever 
activated a 20-sec light and tone (78 dB, 2kHz) compound stimulus, which also served as a 
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time-out period in which lever presses were recorded but had no consequences. The first two 
days of self-administration were capped at 100 and 102 infusions, respectively, to prevent 
overdose. The next 8 days of self-administration was unhindered, after which rats were left 
undisturbed in their home-cage for either 3 or 30 days, depending on withdrawal group. Only 
rats that exhibited stable levels of drug taking over the last 3 days of the self-administration 
phase of the study were tested for the effects of our neuropharmacological manipulations 
upon drug-seeking. Rats were randomly assigned to a microinjection treatment group 
(TBOA vs. vehicle; LY379268 vs. vehicle), with all groups exhibiting equivalent drug 
intake prior to testing.   
4.2.5 Microinjection and Test for Cue-Reinforced Cocaine-Seeking 
DL-threo-β-Benzyloxyaspartic acid (TBOA; Tocris, Minneapolis, MN) was dissolved 
into 0.1 N NaOH and neutralized with 0.1 N HCl, then diluted with sterile water to a 
working concentration of 300 µM. This TBOA concentration was selected for study as it 
elevates extracellular glutamate within the PFC of rats (Melendez et al., 2005) and augments 
a cocaine-conditioned place-preference when infused intra-mPFC in mice (Lominac et al., 
2016). LY379268 (Tocris) was mixed with sterile water to a concentration of 20 mM, a dose 
comparable to that demonstrated previously to lower cocaine-induced behavioral 
sensitization during protracted withdrawal when infused intra-mPFC (Lupinsky et al., 2010). 
Sterile water served for vehicle injections.  
At either 3 or 30 days withdrawal, rats were microinjected bilaterally with 0.5 µl of their 
assigned drug (0.5 µl/min) for one minute. Injectors were then left in place for an additional 
minute to allow drug diffusion. The microinjectors were removed and rats were tethered as 
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per usual, then given a 30-minute test for cue-reinforced responding (Extinction Test), 
during which each lever press resulted in the presentation of the cues associated with self-
administration (i.e., light and tone), but no drug. TBOA infused rats were placed into the 
chambers immediately upon microinjection in a manner consistent with prior 
neuropharmacological studies using this drug (e.g., Kapasova & Szumlinski, 2008; Lominac 
et al., 2016). Rats slated for the LY379268 and LY379268’s corresponding vehicle group 
were left inside the operant chamber (levers retracted, doors open) for ~10 minutes in order 
for the drug to take effect, as conducted in prior neuropharmacological studies (Bossert et 
al., 2004; Counette et al., 2011; Myal et al., 2015), before starting the 30-minute Extinction 
Test.   
At the end of the Extinction Test, rats were anesthetized with 4% isoflurane and 
decapitated in order to extract the brain. Tissue was sliced on a vibratome (Leica, Nussloch, 
Germany) then stained with 0.1% cresyl violet acetate to visualize microinjector placement. 
Only data from rats exhibiting injector placement within the boundaries of the vmPFC 
(prelimbic and/or infralimbic areas) were employed in the statistical analyses.  
4.2.6 Statistical Analyses 
As the four studies of the effects of intra-PL and intra-IL infusion of TBOA and 
LY379268 on incubated drug-seeking were each conducted independently, in series, the data 
from each experiment were analyzed separately. To confirm equivalent cocaine intake across 
the four experimental conditions within each study, the data for the average number of 
cocaine infusions earned during the last 3 days of self-administration training were analyzed 
using a Withdrawal (3 vs. 30 days withdrawal) X Treatment (TBOA/LY379268 vs. vehicle) 
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ANOVA. The behavioral data for the Extinction Test was analyzed by a Withdrawal (3 vs. 
30 days withdrawal) X Treatment (TBOA/LY379268 vs. vehicle) ANOVA. When 
appropriate, interactions were deconstructed using simple effects analyses of group 
differences between 3 and 30 days withdrawal rats. α = 0.05 for all analyses.  
4.3. Results 
4.3.1 Self-Administration Training 
 All rats were trained to self-administer cocaine, then randomly assigned into their 
respective withdrawal time-point and intracranial drug treatment groups. An analysis of the 
number of cocaine infusions earned over the last 3 days of self-administration training failed 
to indicate any group differences in cocaine intake in any of the studies (Withdrawal X 
Treatment ANOVAs, for PL-TBOA: all p’s > 0.08; for PL-LY379268: all p’s > 0.10; for IL-
TBOA: all p’s > 0.30; for IL-LY379268: all p’s > 0.09; see Table 3). 
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Table 3. Mean and SEMs of the number of cocaine infusions earned over the last 3 days of cocaine self-
administration across treatment groups. 
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4.3.2 TBOA Infusion into the Infralimbic, but Not the Prelimbic Cortex, Attenuates the 
Incubation of Cocaine-Seeking 
Localization of the microinjection sites for both vehicle- and TBOA-infused rats are 
presented in Figure 9. In the PL experiment, infusion of TBOA did not affect cue-reinforced 
cocaine-seeking at either 3 or 30 days withdrawal, compared to vehicle [Withdrawal effect: 
p= 0.07; Withdrawal X Treatment: F(1,45)= 0.00, p= 0.99; see Figure 10]. On the other 
hand, TBOA infusion into the IL significantly altered the time-dependent change in cue-
reinforced cocaine-seeking behavior [Withdrawal X Treatment: F(1,38)= 4.18, p= 0.05]. 
Deconstruction of the interaction along the Withdrawal factor indicated that TBOA 
significantly decreased cocaine-seeking at 30 days withdrawal [F(1,19)= 6.23, p= 0.02] but 
not 3 days withdrawal [F(1,19)= 0.55, p= 0.47; Figure 10].  No effect of TBOA infusion was 
observed for inactive lever presses, irrespective of subregion (data not shown) [Treatment X 
Withdrawal ANOVAs, for PL: all p’s> 0.30; for IL: all p’s> 0.40]. These latter results argue 
that TBOA infusion did not produce any adverse motor side-effects that might interfere with 
responding. Further, these data indicate that the intra-IL TBOA effect was selective for the 
formerly cocaine-reinforced lever.   
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Figure 9. Summary of bilateral placements of TBOA & vehicle microinjection cannulae within the PL and IL. 
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Figure 10. Comparison of the total number of active lever presses at 3 vs. 30 days withdrawal during the 
Extinction Test for TBOA- or vehicle-infusion into either the PL or IL. Data represents the means ± SEMs of 
the number of rats indicated in parentheses. *p<0.05 vs. IL-3 days withdrawal vehicle, illustrating an incubation 
of drug-seeking. +p<0.05 vs. IL-30 days withdrawal vehicle. 
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4.3.3 LY379268 Infusion into the Prelimbic, but Not the Infralimbic Cortex, Attenuates 
the Incubation of Cocaine-Seeking 
 Localization of the microinjection sites for both vehicle- and LY379268-infused rats 
are presented in Figure 11. In the PL experiment, LY379268 infusion significantly 
influenced the time-dependent change in cue-reinforced cocaine-seeking [Withdrawal X 
Treatment: F(1,30)= 6.66, p= 0.02; main effect of withdrawal: F(1,30)= 16.10, p< 0.001; 
Figure 12]. Deconstruction of the interaction along the Withdrawal factor demonstrated that 
LY379268 significantly decreased drug-seeking behavior at 30 days withdrawal [F(1,17)= 
9.80, p= 0.006], but did not affect behavior at 3 days withdrawal [F(1,13)= 0.65, p= 0.44]. In 
contrast, intra-IL infusion of LY379268 had no statistically significant effect on drug-
seeking at either time point [Treatment X Withdrawal ANOVA, all p’s > 0.08; Figure 12]. 
No effect of LY379268 was apparent for inactive lever presses (data not shown) [Treatment 
X Withdrawal ANOVAs, for PL: all p’s> 0.06; for IL: all p’s> 0.20]. Thus, LY379268 
infusion did not produce any overt motor side-effects that might interfere with responding. 
Further, these data indicate that the intra-PL LY379268 effect was selective for the formerly 
cocaine-reinforced lever.  
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Figure 11. Summary of bilateral placements of LY379268 & vehicle microinjection cannulae within the PL 
and IL. 
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Figure 12. Comparison of the total number of active lever presses at 3 vs. 30 days withdrawal during the 
Extinction Test for LY379268- or vehicle-infusion into either the PL or IL. Data represents the means ± SEMs 
of the number of rats indicated in parentheses. *p<0.05 vs. PL-3 days withdrawal vehicle, illustrating an 
incubation of drug-seeking. +p<0.05 vs. PL-30 days withdrawal vehicle. 
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4.4. Discussion 
Extracellular glutamate levels are elevated in the vmPFC during incubated cocaine-
seeking (Shin et al., 2016). However, at the outset of this study, the functional relevance that 
elevated glutamate plays in incubated drug-seeking was unknown. The vmPFC is subdivided 
into the PL and IL subregions, which are theorized to play opposing roles in regulating drug-
seeking behavior, including the incubation of drug-seeking during protracted withdrawal 
(Ma et al., 2014; Ball et al., 2012). Through neuropharmacological manipulation of 
endogenous glutamate within the PL and IL, the present study demonstrated that endogenous 
glutamate in the PL is necessary, but not sufficient, for incubated drug-seeking as the local 
application of a mGlu2/3 autoreceptor agonist attenuated, while infusion of the non-selective 
neuronal EAAT inhibitor TBOA did not affect, incubated drug-seeking. Conversely, in the 
IL, local application of TBOA abolished incubated drug-seeking, while mGlu2/3 agonism 
produced no significant effect. Lastly, these neuropharmacological manipulations of 
endogenous GLU did not affect drug-seeking during short-term withdrawal, indicating a 
more critical role for excitatory glutamate neurotransmission within the vmPFC in regulating 
the increased cue-reactivity observed during protracted withdrawal.   
4.4.1 Glutamate Manipulations Influence Drug-Seeking Behavior During Protracted, But 
Not Short-Term, Withdrawal  
All drug effects observed in the present study were selective for protracted withdrawal. 
As none of our manipulations altered behavior during early withdrawal, it is unlikely that the 
reduction in incubated drug-seeking produced by our manipulations reflects gross 
impairments in general motivation, motor activity or cognitive function (i.e., the ability to 
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recall the drug-cue/context association or the operant response). The temporal specificity of 
our drug effects for later withdrawal supports previous incubation studies in which 
neuropharmacological or peptide manipulations of either the cell body (Ben-Shahar et al., 
2013; Miller et al., 2016; present study) or terminal (Conrad et al., 2008; Fischer et al., 2013; 
Li et al., 2013; Loweth et al., 2014) regions of corticoaccumbens projections, along with the 
general CEA (Lu et al., 2007), exerted effects on drug-seeking only in protracted withdrawal. 
These behavioral results, coupled with prior in vivo microdialysis (Shin et al., 2016), 
immunoblotting (Boudreau & Wolf, 2005; Lu et al., 2005; Ghasemzadeh et al., 2011; Ben-
Shahar et al., 2013; Miller al., 2016) and electrophysiological (Lee et al., 2013; Ma et al., 
2014; Scheyer et al., 2016) evidence, further support the argument that the neural substrates 
of incubated cue-reinforced drug-seeking are distinct from those underpinning drug-seeking 
per se and that the passage of time in withdrawal is critical for the neuroadaptations within 
vmPFC that bring this structure “on-line” in protracted withdrawal to augment behavioral 
reactivity to drug-associated cues (Wolf, 2016; Shin et al., 2016). Indeed, others have also 
hypothesized glutamate-mediated mechanisms are involved in incubated versus non-
incubated cocaine-seeking (Lu et al., 2005; Lu et al., 2007). 
The neurophysiological properties of terminals within specific corticoaccumbens and 
amygdaloaccumbens projections are markedly different in early versus later withdrawal (Lee 
et al., 2013; Ma et al., 2014). Specifically, glutamate projections from the vmPFC to the 
NAC (Ma et al., 2014), as well as projections from the basolateral amygdala to NAC (Lee et 
al., 2013), undergo silencing or dematuration during early drug withdrawal. However, with 
the passage of time in withdrawal, these synapses re-mature and become “unsilenced”, 
owing to the insertion of specific AMPA receptor subunits, and possibly other yet unknown 
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molecular adaptations that augment synapse excitability (Lee et al., 2013; Ma et al., 2014). 
Currently, it is not known whether or not synapses within the vmPFC proper also undergo 
similar forms of time-dependent metaplasticity. However, if synapse silencing does occur 
during early withdrawal in glutamate synapses within vmPFC, such a phenomenon might 
account for the relative ineffectiveness of our glutamate manipulations, as well as other 
neuropharmacological manipulations of the vmPFC (e.g., Ben-Shahar et al., 2013; Miller et 
al., 2016; present study), at earlier withdrawal time-points.  
4.4.2 Endogenous Glutamate in the Prelimbic Cortex is Necessary, but Not Sufficient, for 
Incubated Drug-Seeking 
Stimulation of mGlu2/3 autoreceptors via LY379268 infusion into the PL significantly 
attenuated incubated drug-seeking, implicating endogenous glutamate within this subregion 
as a critical mediator of incubated responding. Our neuropharmacological result is consistent 
with evidence that the PL is implicated in cue-induced reinstatement (Capriles et al., 2003; 
Zavala et al., 2008; McGlinchey et al., 2016), with PL projections to the NAc core being 
recruited during, and in proportion to, cue-induced reinstatement of cocaine-seeking 
(McGlinchey et al., 2016). Further, inactivation of the PL is known to attenuate stress-
induced, cue-induced, and cocaine-induced reinstatement of drug-seeking (Capriles et al., 
2003; McLaughlin & See, 2003; Fuchs et al., 2004; Di Pietro et al., 2006), supporting a 
critical role for this vmPFC subregion in these animal models of relapse. More directly 
relevant to incubated cocaine-seeking, the PL exhibits enhanced coding of cocaine-
associated stimuli (West et al., 2014), and the PL projection to the NAC core is strengthened 
(Suska et al., 2013; Ma et al., 2014; Luís et al., 2016) during protracted withdrawal from 
chronic cocaine self-administration. Further, the strengthening of this pathway coincides 
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with increased electrophysiological indices of presynaptic glutamate release from PL-NAC 
projections (Suska et al., 2013; Luís et al., 2016). Taken together, we propose that a time-
dependent increase in glutamate release within the PL is at least one neurochemical substrate 
driving the enhanced encoding of cocaine-associated cues by this subregion, as well as the 
resultant metaplasticity within the NAC (and other terminal regions) culminating in greater 
cue-reactivity and incubated responding. Important questions for future work relate to (1) the 
source of the glutamate within the PL that incubates during protracted withdrawal and is 
critical for the manifestation of incubated responding, (2) the neuronal or glial adaptations 
that occur within the PL resulting in increased cue-reactivity of glutmate and (3) the specific 
glutamate receptors activated by incubated drug-seeking glutamate release within the PL that 
promote the synaptic strengthening of corticoaccumbens projections to drive incubated 
responding.   
At the outset of study, we hypothesized that if the cue-induced increase in glutamate 
within the PL drives incubated responding, then augmenting endogenous glutamate levels 
within this subregion via an infusion of the EAAT inhibitor TBOA might increase the 
magnitude of the incubated response. In contrast to our hypothesis, intra-PL TBOA infusion 
did not significantly affect drug-seeking in later withdrawal. This negative result does not 
likely reflect the dose of TBOA employed as 300 µM TBOA is within the range reported to 
produce a 2- to 3-fold increase in glutamate within PFC (Melendez et al., 2005) and, as 
discussed below, this dose was effective at altering incubated responding when infused into 
the IL. Given that responding for cocaine-associated cues during protracted withdrawal 
results in a near-doubling of glutamate within the vmPFC that is maintained throughout a 2-
h cue-reinforced extinction-like test (Shin et al., 2016), it is likely that the failure to observe 
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a potentiation of incubated drug-seeking by intra-PL TBOA infusion reflects a ceiling effect 
upon behavior. This being said, intra-PL TBOA infusion did not augment cocaine-seeking 
expressed by rats tested during early withdrawal – a time when cocaine-associated cues do 
not influence glutamate within vmPFC (Shin et al., 2016) – and thus a time point where an 
effect of TBOA should be apparent. Alternatively, given our findings for LY379268, the 
possibility exists that elevating endogenous glutamate prior to the test for incubated drug-
seeking engaged autoregulatory and/or presynaptic axoaxonal inhibitory mechanisms that 
occluded our ability to detect behavioral potentiation. Indeed, incubated cocaine-seeking 
tended to be suppressed by intra-PL TBOA infusion in the present study, suggesting the 
possibility that inhibitory mechanisms may have been engaged by TBOA pretreatment.   
The PFC expresses the glial transporters EAAT1 and EAAT2, as well as the neuronal 
transporter EAAT3 (Danbolt, 2001). The reported IC50 of TBOA for each of these 
transporters is 70 µM, 6 µM and 6 µM, respectively (Jabaudon et al., 1999) and thus, the 
300 µM TBOA dose employed in the present study is well above that predicted to inhibit all 
three transporters. Indeed, intra-PFC infusion of TBOA doses between 250 and 500 µM is 
sufficient to produce a robust local increase in extracellular glutamate (while manipulations 
of sodium-independent transporters are without effect) (Melendez et al., 2005), the relative 
contribution of glutamate release from glia versus neuronal sources and the role for sodium-
dependent glial transporters in the maintenance and regulation of vmPFC glutamate remains 
to be determined, to the best of our knowledge. Thus, while it is presumed that the incubated 
glutamate release observed when rats respond for cocaine-associated cues (Shin et al., 2016) 
is derived from neuronal sources (a likely candidate being thalamocortical projections), there 
is no evidence negating the contribution of glia to this phenomenon. Thus, the intriguing, 
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although speculative, possibility exists that the failure of TBOA to influence incubated drug-
seeking reflects a greater involvement of glia-derived glutamate, which will be tested in 
future studies by manipulating EAAT1 expression.       
4.4.3 Increased Endogenous Glutamate in the Infralimbic Cortex is Sufficient to Block 
Incubated Drug-Seeking  
In contrast to the PL, inhibition of glutamate re-uptake via TBOA infusion within the IL 
blocked incubated drug-seeking, arguing an inhibitory role for endogenous glutamate within 
this subregion. These neuropharmacological results complement the extant literature 
pertaining to the reinstatement of drug-seeking demonstrating that IL activation with AMPA 
agonists reduces cocaine-primed reinstatement of drug-seeking (Peters et al., 2008; 
LaLumiere et al., 2010). Further, our results are in line with optogenetic evidence 
demonstrating that activation of IL projections to the NAC shell inhibits incubated cocaine-
seeking (Ma et al., 2014) and extend these findings by implicating glutamate as an upstream 
mediator of this effect. It is noteworthy that in an earlier study by Koya et al. (2009), the 
local infusion of an inhibitory GABA agonist cocktail into the more ventral aspect of the 
vmPFC decreased incubated cocaine-seeking. While this result may seem contrary to the 
present findings, the microinjection sites in this prior study were not localized exclusively to 
the IL, with a fraction of the microinjections localized more dorsally within the PL (Koya et 
al., 2009). Given the present observations for LY379268’s effects within the PL and earlier 
optogenetics work (Ma et al., 2014), the inhibitory effect of the GABA agonist cocktail 
observed in Koya et al. (2009) could reflect the effects of inhibiting PL projections.  
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The above being said, an inspection of Figure 12 indicates that the magnitude of the 
intra-IL LY379268 effect upon incubated behavior was comparable to that produced by an 
intra-PL infusion of this mGlu2/3 agonist. Further inspection of Figure 12 suggests that the 
failure to detect a statistically significant effect of intra-IL LY379268 infusion likely 
reflected the variability in cue-reinforced responding observed in the vehicle-infused 
controls in this particular experiment. The reduction in incubated drug-seeking upon intra-IL 
LY379268 infusion is peculiar in light of the discussion presented above, as well as prior 
work indicating little to no effect of IL inactivation upon stress- or cocaine-primed 
reinstatement of drug-seeking (Caprilles et al., 2003), or upon cue-primed reinstatement of 
MDMA-seeking (Ball et al., 2012). Further, in contrast to the PL, IL neurons do not exhibit a 
withdrawal-dependent enhancement of the encoding of cocaine-associated stimuli (West et 
al., 2014). Although a body of literature argues an important role for IL activity in 
suppressing drug-seeking behavior, other data argue that IL activation may, in fact, drive 
such behavior (see Moorman et al., 2015 for detailed review). As one example, lesions of 
either the PL or the IL are reported to reduce cocaine-seeking after 7 days of withdrawal 
(Pelloux et al., 2013). Notably, however, the effect of the IL lesion was more modest than 
that observed for the PL, which is a finding consistent with the data in Figure 12.  
Furthermore, immunohistochemical data indicate high levels of cellular activation within the 
IL when animals are exhibiting drug-seeking or drug-conditioned behaviors (e.g., Franklin 
and Druhan, 2000; Hamlin et al., 2008; Koya et al., 2009; Moorman and Aston-Jones, 2015; 
Nic Dhonnchadha et al., 2012; Zavala et al., 2007, 2008). Given the complexity of the 
vmPFC and the large overlap in projections from the PL and IL (Heidbreder and 
Groenewegen, 2003; Moorman et al., 2015a; Vertes, 2004, 2006), it is entirely possible that 
the increased cue-reinforced glutamate release observed in our prior study (Shin et al., 2016) 
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emanated from either the PL or the IL (or both) to drive incubated drug-seeking. This 
hypothesis remains to be addressed empirically.   
4.4.4 Conclusions  
In conclusion, the present study demonstrates that endogenous glutamate in the vmPFC 
is necessary for the manifestation of incubated drug-seeking during protracted withdrawal, 
while elevating endogenous glutamate within the IL is sufficient to attenuate this behavioral 
phenomenon. In contrast, manipulations of endogenous glutamate within neither region 
altered, in any obvious manner, drug-seeking expressed during early withdrawal. These 
neuropharmacological data extend prior correlative evidence of a relationship between 
vmPFC glutamate and the incubation of cocaine-seeking and argue a critical role for the 
incubation of glutamate release within  “pro-relapse circuits” involving the PL (and perhaps 
also the IL) in the incubation of cue-reactivity during extended drug abstinence. If relevant to 
the human condition, these data highlight the potential pharmacotherapeutic utility of 
glutamate autoreceptor agonists as a viable strategy for curbing excessive cue-reinforced 
craving during protracted withdrawal and facilitating addiction recovery.  
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Chapter 5: 
General Discussion 
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5.1 Summary of Studies & Findings 
The data presented in this dissertation are the first to elucidate the role of endogenous 
glutamate in the PL and IL subregions of the vmPFC during incubated cocaine-seeking. In 
Experiment 1, adult male rats were trained to self-administer IV cocaine in a LgA paradigm 
for ten consecutive days, after which they were kept in their home cage for either 3 or 30 
days of withdrawal (WD). At either 3 or 30WD, rats underwent microdialysis procedures on 
one hemisphere of the brain during a cue-reinforced cocaine-seeking test (Extinction Test). 
This experiment determined that there was a time-dependent increase in extracellular 
glutamate (GLUEC) in the vmPFC selective for cocaine-trained rats, as these changes were 
not apparent in sucrose- or neutral cue-trained rats. These time-dependent increases in 
GLUEC were positively correlated to incubated cocaine-seeking.  
As mGlu2/3 receptors are essential in the regulation of GLUEC, it was hypothesized that 
mGlu2/3 receptors internalize during protracted withdrawal, thus producing the increase in 
GLUEC observed during protracted withdrawal in Experiment 1. Thus, Experiment 2 was 
designed to begin to test this hypothesis. Western immunoblotting was performed on the 
other, manipulation-free, hemisphere from the rats in Experiment 1, in order to ascertain 
mGlu2/3 levels in the vmPFC during short (3) or protracted (30) withdrawal. However, no 
changes in total mGlu2/3 expression were found at either time point. Hitherto, I ascertained 
that elevated GLUEC in the vmPFC is correlated with incubated cocaine-seeking, but that 
this effect is likely unrelated to a change in the total protein expression of mGlu2/3 
receptors.  
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As the results from Experiments 1 and 2 were correlational in nature, the question of 
vmPFC glutamate’s functional relevance for cocaine-seeking, and its incubation, remained. 
Thus, Experiment 3 was designed to explore this question, using neuropharmacological 
approaches. After stable LgA cocaine SA was achieved, rats were again withdrawn from 
cocaine for either 3 or 30 days, at which time point they were exposed to an Extinction Test. 
As the PL is implicated in driving drug-seeking, while the IL is implicated in its supression, 
each subregion was targeted separately. Before the Extinction Test, endogenous glutamate 
was manipulated in either the PL or IL through microinjection of the EAAT inhibitor, TBOA 
(to raise glutamate levels), or the mGlu2/3 agonist, LY379268 (to lower glutamate 
levels/prevent release). In the PL, preventing the normal rise in glutamate found during 
30WD via LY379268 infusion blocked incubated cocaine-seeking behavior, while 
increasing glutamate via TBOA infusion had no significant effects on behavior. In the IL, the 
results were less clear-cut; decreasing endogenous glutamate at 30WD reduced drug-seeking 
to a similar extent as that observed for the PL, but the effect was not statistically significant. 
In contrast, increasing glutamate in the IL via TBOA infusion significantly blunted incubated 
behavior. These results are consistent with the theory that the PL plays a necessary, but not a 
sufficient, role in driving cue-reinforced drug-seeking behavior, while the IL plays a more 
complicated role in regulating incubated drug-seeking behavior. Together, the three 
experiments in this dissertation point to glutamate within both subregions of the vmPFC as 
critical driving factors for incubation of cocaine craving. 
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5.2 Implications of Findings 
As discussed in the General Introduction, the state of our knowledge regarding the PFC’s 
role in the incubation of cocaine craving at the outset of this dissertation was limited. At that 
time, it was known that the vmPFC was involved in incubated cocaine-seeking, as 
inactivating this region abolished drug-seeking at protracted, but not short-term withdrawal 
(Koya et al., 2009). Over the course of the past five years (2012-2017), research on the 
incubation of cocaine seeking has exponentially increased, but most work has predominately 
focused on the NAC, as indicated in various reviews of incubation of cocaine seeking (e.g., 
Wolf, 2016; Li, Caprioli, & Marchant, 2015; Pickens et al., 2011). Despite some progress, 
the PFC is still clearly understudied within the context of incubated drug-seeking and more 
research needs to be done in order to have a more solid understanding of how PFC 
subregions contribute to this clinically relevant phenomenon.  
5.2.1. Challenging the Anatomical Dichotomy of the Prelimbic and Infralimbic Cortex in 
Incubated Drug-Seeking  
Along with the pro- and anti-relapse circuit of incubated craving not being clear cut, the 
PL and IL are also not so clearly defined, at least if based on anatomical connectivity alone. 
As mentioned in section 1.2.2, the PL and IL have extensive overlap in their projections, but 
they also have clear differences. Using the anterograde anatomical tracer, phaseolus 
vulgaris-leucoagglutinin (PHA-L), Vertes was able to record the projections of the PL and 
IL (Vertes, 2004). As much of the literature on incubated cocaine-seeking points to the 
heavy involvement of the mPFC to NAC circuit, I will focus on these projections. 
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It is known that the PL and IL both project to the NAC core and shell, respectively, but 
what is not usually described are the differing pattern and extent of their projections. In 
reality, the mPFC projections to the NAC mainly originate from the PL as the NAC is one of 
the main projection sites of the PL. The PL has fibers distributing throughout both the core 
and shell, but these fibers tend to terminate more heavily in the core. The rostral PL is 
known to distribute more heavily to the NAC core, as well as a slight tendency for the dorsal 
PL to project more dominantly to the core and the ventral PL to the shell. In contrast, the IL 
has significantly less labeling of fibers to the NAC, as the NAC is not one of the main 
projections of this region. The few projections the IL extends to the NAC terminate in both 
the NAC core and shell, with a slight preference to the shell.  
The anatomical complexity increases as both the PL and IL project to each other, as well 
as projecting to itself. For example, the PL to NAC projection is the first step of the PL 
cortical loop to itself, called the PL-ventral striatopallidal-thalamocortical circuit. More 
specifically, the loop consists of the PL projecting to the NAC, which projects to the ventral 
pallidum and substantia nigra, to the mediodorsal nucleus, and back to itself. Thus, even 
though functional dichotomy exists between the two regions, it is clear that it will be hard to 
parse apart and producing mixed results are inevitable due the complexity of connections 
(e.g., Pelloux et al., 2013 results of IL compared to anterior IL; see Section 5.2.2.).  
5.2.2. Imperfect Functional Mapping of the Infralimbic Cortex in Drug-Seeking  
The pro-/anti-relapse dichotomy of the PL and IL cortices is likely too much of an overly 
simplistic view of the functional neurocircuitry underpinning any behavior or psychological 
process. Indeed, evidence calls into question if the anti-relapse IL region is truly involved in 
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the suppression of cocaine-seeking (see Moorman et al., 2015 for a comprehensive review). 
For example, inactivation of the IL (as well as the PL) decreased cocaine-induced 
reinstatement (Vassoler et al., 2013). Pelloux and colleagues report that after 7 days forced 
abstinence, lesions of the PL decreased context-induced cocaine-seeking after a battery of 
tests, some of which included progressive ratio schedule and intermittent punishment, with 
lesions of the IL exhibiting a trend toward decreased seeking as well (Pelloux et al., 2013). 
Interestingly, anterior IL lesions were able to significantly increase seeking responses 
compared to controls (Pelloux et al., 2013), which indicate that within the same subregion, 
functionality may differ.    
Indeed, this may partially explain the unconventional results reported in Chapter 4. In the 
IL, either increasing (TBOA infusions) or decreasing endogenous glutamate (LY379268 
infusions) seemed to produce similar behavioral results: cue-induced cocaine-seeking was 
blunted during protracted withdrawal (see Figures 10 and 12). Although not statistically 
significant compared to controls, decreasing glutamate in the IL during protracted 
withdrawal seemed to blunt incubated drug-seeking. Unfortunately, the thickness of my 
brain sections were too thick (75µM) to accurately deduce where injectors were placed. 
Figures 9 and 11 suggest they ever so slightly tend to land more posterior, but as I still have 
a significant number of injections in both anterior and posterior IL, the data is difficult to 
interpret in regards to the functional split between regions within the IL. Though both studies 
study cocaine relapse in the context of drug-seeking, these studies still differed 
methodologically to the incubation model used in my experiments so these results must be 
taken into consideration with caution. Of course, it may as well be possible that the evidence 
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for extinction/reinstatement and incubation may not differ so much in regards to the IL 
driving drug-seeking, but as of yet, no empirical evidence has tested this theory.  
On the other hand, evidence arguing against the role of the PL in some general role in 
driving drug-seeking is less compelling. For example, inactivation of the PL enhanced cue-
induced reinstatement of heroin-seeking (Schmidt et al., 2005), while inactivation of the PL 
also did not disrupt seeking induced by a cocaine-associated conditioned reinforcer (Di 
Ciano et al., 2007). It should be noted, however, the studies providing conflicting roles were 
mostly carried out in extinction/reinstatement models and not in the context of incubated 
drug-seeking. As these two paradigms are known to differentially impact both cellular and 
molecular changes in the brain (see section 1.4.1), it is possible that the results pertaining to 
the do not extend to the phenomena of incubation. In addition to utilization of different 
paradigms, most studies supporting this role of the PL focus on other reinforcers (e.g., 
heroin, sucrose, etc.) and not cocaine. Indeed, within the same incubation of craving 
paradigm, different reinforcers are known to recruit different brain regions (see section 1.4.3 
and Table 1). Even evidence from my own work shows neurochemical differences between 
incubated sucrose versus cocaine-seeking (Chapter 3). Thus in the context of incubation of 
cocaine-seeking, the theory of the pro-relapse PL region may still hold and must be tested 
empirically.  
5.3 Limitations & Future Directions 
The data presented in this dissertation elucidate the functional role of glutamate in the PL 
and IL subregions of the vmPFC during incubated cocaine-seeking, yet many questions still 
remain. To address these questions, the following experiments are proposed: 
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(1) Characterize the molecular regulation of incubated glutamate release in the PL and 
IL. Along with bifurcating the role of GLUEC in the PL and IL, the same needs to be done on 
the observed immunoblotting results of mGlu2/3 in the vmPFC (Chapter 3) before claiming 
mGlu2/3 are not involved in incubated cocaine-seeking. While research has shown that the 
PL and IL differentially regulate mGlu2/3 receptors during protracted withdrawal in alcohol-
dependent rats (Meinhardt et al., 2013), further testing needs to be done on mGlu2/3 levels 
in the specific subregions of the vmPFC to ensure the same is not occurring during 
protracted withdrawal from chronic cocaine. As I dissected the whole vmPFC without 
separating PL and IL for the immunoblots, it is possible that changes in mGlu2/3 levels were 
not detected as they negated each other due to opposite regulation of the protein in the PL 
and IL. In addition, other assays can be used in order to further probe mGlu2/3 such as 
dimers, cell surface expression, post-translational modifications, etc.  
(2) Characterize the role of calcium permeable (CP) and calcium impermeable (CI) 
AMPAR in the PL and IL. AMPAR within both the BLA and NAC play an important role in 
the incubation of cocaine craving (Conrad et al, 2008; Loweth et al., 2014; McCutcheon et 
al., 2011), raising the possibility that stimulation of these receptors within vmPFC, 
specifically the PL, by cue-reinforced glutamate release (Shin et al., 2016) might drive 
incubated drug-seeking behavior. Indeed, recent optogenetic work shows that silent 
glutamatergic synapses are generated in the vmPFC projections to the NAC during 
withdrawal from chronic cocaine, with these synapses eventually maturing/unsilencing via 
insertion of CI-AMPAR in the PL and CP-AMPAR in the IL during protracted withdrawal 
(Ma et al., 2014). The optogenetic reversal of this synapse maturation within PL-NAC 
projections decreased incubated drug-seeking, while that within the IL-NAC projections 
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potentiated incubated drug-seeking behavior. Similar work has been done in the BLA to 
NAC shell pathway, as reversing the maturation of silent synapses through downregulation 
of CP-AMPAR decreases incubated drug-seeking behavior (Lee et al., 2013). CP-AMPA are 
also implicated in the VTA as they accumulate in this region as well (Mameli et al., 2007; 
Chen et al., 2008). Despite this recent work, no neuropharmacological evidence exists 
directly linking AMPAR subtypes in the vmPFC to incubation of craving. Thus, future work 
should address this question by pharmacologically blocking CP- and CI-AMPAR using 1-
naphthylacetylspermine (Naspm) and 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX), 
respectively, in order to test the hypothesis that CI-AMPAR, but not CP-AMPAR, in the PL 
are functionally relevant for the incubation of cocaine-craving.  
(3) Characterize the time-course of GLUEC in the PL and IL, individually, during the 
incubation of cocaine-seeking. While Chapter 2 examined GLUEC levels in the overall 
vmPFC during incubated cocaine-seeking, Chapter 4 makes clear that the PL and IL of the 
vmPFC are differentially involved in incubation. While we were limited by the length of our 
dialysis probes (2mm long), which precluded the possibility to be able to parse out dialysate 
stemming from the PL or IL (regions that are approximately 1mm), future studies utilizing a 
more refined microdialysis technique using 1 mm probes need to be run in order to 
determine the individual contribution of the PL and IL to elevated GLUEC in the vmPFC. 
Results from Chapter 4 suggest that the elevated GLUEC reported from Chapter 1 mainly 
stems from the PL during incubated cocaine-seeking, but this has not yet been confirmed 
empirically.   
(4) Characterize the origin of glutamate that drives the time-dependent changes in 
vmPFC glutamate. Chapter 4 illustrated glutamate in the PL is functionally relevant in 
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incubated drug-seeking, which most likely drives the similar increase of GLUEC exhibited in 
the NAC (McFarland et al., 2003; Suto et al., 2010) as the PL is one of the main glutamate 
afferents of the NAC core. Yet the question of where the increase of GLUEC in the vmPFC 
originates arises. It can be that it all originates from the vmPFC itself, but another equally 
likely hypothesis is that it comes the thalamus. Indeed, the PL and IL both have strong 
afferent projections stemming from the mediodorsal nucleus (MDT), paratenial nucleus, 
paraventricular thalamic nucleus (PVT), nucleus reuniens, and rhomboid nucleus of the 
thalamus (Hoover & Vertes, 2007), making these nuclei a likely candidate. Although limited 
pre-clinical research has been done on the thalamus in the scope of drug addition, compared 
to the PFC, emerging evidence makes it clear this region is involved, particularly the PVT. 
For example, the thalamus of cocaine-dependent human subjects are known to exhibit lower 
gray matter volume (Sim et al., 2007; Garza-Villarreal et al., 2017). Pre-clinical reports also 
mirror this conclusion as lesions to the PVT block cocaine sensitization (Young and Deutch, 
1998), which is another time-dependent phenomenon in which behavior intensifies in drug-
experienced animals. Further, re-exposure to a cocaine-paired environment activates PVT 
neurons (James et al., 2011; Pelloux et al., 2017), and baclofen+muscimol (B/M) 
inactivation of the PVT blocks expression of a cocaine-conditioned place preference 
(Browning et al., 2014). Of more direct relevance to the work presented in this thesis, B/M 
inactivation of the PVT blocks cue-induced reinstatement (Matzeu et al., 2015), along with 
cocaine-primed reinstatement of drug-seeking (James et al., 2010), while having no effects 
on sweetened condensed milk seeking behaviors (Matzeu et al., 2015). Other regions of the 
thalamus may also play a role in cocaine addiction as lesions to the MDT decreases the rate 
of IV cocaine self-administration (Weissenborn et al., 1998). However, other thalamic nuclei 
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have not yet been extensively studied in the scope of cocaine addiction. However, the 
evidence implicates the thalamus and its nuclei in addiction, warranting further study. 
(5) Characterize the sex differences of incubation of cocaine-seeking. As this 
dissertation utilized adult male rats, all studies should be extended to include females as 
well, as females are known to be more sensitive to relapse in both human and animal 
models. Clinical studies report female addicts are more reactive to drug-associated stimuli 
and have higher rates of relapse compared to males (e.g., Becker, 2016; Bobzean et al., 
2014). These findings extend to rodent models, as female rats are more sensitive to cocaine-
primed reinstatement (Lynch et al., 2000), exhibit more activity on the active lever during 
reinstatement (Lynch et al., 2000b; Kippin et al., 2005; Kersetter et al., 2008), and exhibit 
more enduring incubated cocaine-craving (Kersetter et al., 2008) compared to their male 
counterparts. Parsing the source of sex-specific differences in cocaine incubation will be the 
task of future researchers. 
5.4 Conclusion 
 In summary, this dissertation provides novel insight into the role of glutamate in the 
vmPFC during incubated drug-seeking following a history of long-access cocaine self-
administration. The results are the first of their kind to indicate that glutamate in the PL (and 
perhaps also the IL) is functionally relevant for cue-induced cocaine-seeking during 
protracted withdrawal. The data complements existing literature that PL-NAC core 
glutamate projections may be driving the enhanced encoding of cocaine-associated cues by 
this subregion (Suska et al., 2013; Luís et al., 2017), as well as the resultant metaplasticity 
within the NAC (and other terminal regions) culminating in greater cue-reactivity and 
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incubated responding. Together, the data within this dissertation add to the limited literature 
highlighting the importance of the PFC during incubated cocaine craving, and to our general 
understanding of the neurobiology of cocaine addiction.  
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